Aneurysms, operations, SAH

I9_SAHANEUR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_ANEUR I9_ANEURYSM I9_SAH	7026
6. Filter based on genotype QC (FinnGen only)	7026

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_SAHANEUR
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_ANEUR\|I9_ANEURYSM\|I9_SAH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Aneurysms, operations, SAH based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	62174	32691	28490
Only index persons	40631	22510	18121
Unadjusted period prevalence (%)
Whole population	0.87	0.94	0.80
Only index persons	0.77	0.83	0.69
Median age at first event (years)
Whole population	57.71	59.42	55.75
Only index persons	57.42	58.55	56.02

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7026	3992	3034
Unadjusted period prevalence (%)	1.35	1.36	1.34
Median age at first event (years)	56.92	56.29	57.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6415: Matched controls
64150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

323.0

430

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

2141.2

323.0

422

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

6118.2

323.0

1052

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

323.0

563

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

129.6

323.0

922

2161

FHL

Neck ligation, big brain

+∞

323.0

429

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

323.0

1568

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

323.0

316

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

4079.5

323.0

1855

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1382.3

323.0

390

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

561.0

323.0

1042

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

971.2

323.0

367

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

64.6

323.0

964

175

AAF00

NOMESCO Finland

Ventriculostomy

135.8

323.0

431

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

106.2

323.0

808

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

323.0

416

AA1AD

NOMESCO Finland

CT of head and brain

5.7

323.0

2853

7875

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

10415.0

323.0

2969

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

323.0

434

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

323.0

673

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

477.6

323.0

801

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

660.3

320.9

315

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

323.8

303.6

306

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

2881.5

297.9

286

K90

ICPC

Stroke/cerebrovascular accident

34.1

292.3

386

120

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

591.9

288.2

284

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

304.0

258.0

261

R51.80

ICD-10 Finland

Headache

3.6

254.1

1315

4237

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

+∞

246.4

235

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

243.2

232

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

+∞

243.2

232

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.3

233.8

1419

5135

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

+∞

220.0

210

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

49.8

220.0

268

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

6.1

216.4

637

1146

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

212.6

203

XA800

NOMESCO Finland

Neuropsychological investigation

8.4

206.9

479

609

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

201.1

192

N03AB02

ATC

phenytoin; systemic

19.5

197.9

307

165

B01AC04

ATC

clopidogrel; oral

3.0

191.5

1278

4862

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

7.7

189.7

466

649

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.3

189.3

780

2017

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.2

183.6

759

1966

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

182.9

1392

5748

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

913.7

182.2

178

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

15.7

174.3

293

195

43099

ICD-8 Finland

Subarachnoid haemorrhage, Without mention of hypertension

+∞

173.7

166

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

171.6

164

G91.0

ICD-10 Finland

Communicating hydrocephalus

37.4

168.2

217

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

7.2

161.9

412

602

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.8

160.2

485

894

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

+∞

160.0

153

PA2AD

NOMESCO Finland

CT angiography of brain

63.4

158.3

185

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

+∞

156.9

150

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

34.1

153.4

202

ZXD05

NOMESCO Finland

Urgent procedure

2.2

151.8

2208

12568

K91

ICPC

Cerebrovascular disease

29.8

150.5

205

AA5PD

NOMESCO Finland

CT examination of brain pefusion

58.6

149.6

177

AA9CW

NOMESCO Finland

110.8

148.8

162

N03AX14

ATC

levetiracetam; systemic

8.4

145.3

334

416

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

142.4

143.9

153

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

138.0

1193

5212

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

136.9

131

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

15.6

135.7

228

151

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

10.5

129.6

262

260

N18

ICPC

Paralysis/weakness

13.3

125.7

226

176

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

1221.3

123.3

120

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.6

122.6

604

1797

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

90.6

119.5

133

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

9.1

119.4

261

298

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.8

114.9

345

625

H53.4

ICD-10 Finland

Visual field defects

9.9

114.6

238

248

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

14.1

109.9

192

140

205

Kela drug reimbursment

Chronic hypertension

1.9

106.8

2046

12581

I63.8

ICD-10 Finland

Other cerebral infarction

138.5

102.3

109

R4150

NOMESCO Finland

Neuropsychological rehabilitation

27.4

102.3

142

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

101.3

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

97.3

3820

29382

N03AF02

ATC

oxcarbazepine; oral

5.2

93.5

308

621

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

88.7

Z2445

NOMESCO Finland

Psychologist

4.9

88.2

305

648

N03AF01

ATC

carbamazepine; oral, rectal

3.4

87.6

460

1428

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

299.4

86.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

85.2

625

2432

ZXD35

NOMESCO Finland

Usual procedure

4.2

85.1

345

860

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.9

83.3

216

322

PA7BD

NOMESCO Finland

CT angiography of neck and brain

8.4

81.6

186

228

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

57.3

81.1

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

6.2

80.2

226

377

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

13.5

78.9

140

106

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

43.2

78.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.9

77.7

269

572

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.6

77.5

373

1079

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

87.2

77.1

R42

ICD-10 Finland

Dizziness and giddiness

1.9

75.3

1401

8330

C08CA06

ATC

nimodipine; systemic

83.1

73.1

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

45.6

73.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

73.1

2315

16215

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

73.0

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

72.0

G44.2

ICD-10 Finland

Tension-type headache

2.2

71.8

849

4213

N03AG01

ATC

valproic acid; systemic, rectal

3.1

70.5

422

1435

XCK00

NOMESCO Finland

Perimetry

2.6

68.2

531

2128

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

10.7

68.2

135

129

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

4.4

67.0

256

602

WX882

NOMESCO Finland

High dependency care

4.2

65.6

261

638

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

65.0

947

5113

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

30.4

64.7

C08CA01

ATC

amlodipine; oral

1.6

62.7

2257

16179

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

9.0

61.2

133

151

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

85.9

61.0

R4120

NOMESCO Finland

Occupational therapy

2.9

60.9

388

1373

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

7.5

59.7

145

197

I60

ICD-10 Finland

Subarachnoid haemorrhage

573.1

57.7

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

55.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

55.2

1808

12546

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

542.5

54.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

53.8

431

1752

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

267.9

52.2

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.2

52.2

294

957

TAB00

NOMESCO Finland

Lumbar puncture

3.1

52.1

307

1031

ZXM40

NOMESCO Finland

Use of fluorescent substance

55.9

51.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

51.1

465

2021

XX4AW

NOMESCO Finland

34.0

49.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.2

48.5

275

896

R47.0

ICD-10 Finland

Dysphasia and aphasia

14.2

48.3

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

+∞

48.0

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.5

47.7

100

107

N02BE01

ATC

paracetamol; systemic, rectal

1.6

47.6

5254

47345

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

241.7

47.0

43000

ICD-8 Finland

Subarachnoid haemorrhage, Post aneyrisma sacculare, cum hypertonia

+∞

46.9

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

45.9

H53.2

ICD-10 Finland

Diplopia

3.4

45.1

226

674

C10AA05

ATC

atorvastatin; oral

1.5

44.1

2224

16867

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

+∞

43.8

R51

ICD-10 Finland

Headache

2.7

42.7

307

1170

N19

ICPC

Speech disorder

9.1

42.6

101

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

9.3

42.6

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

14.2

42.6

B01AC07

ATC

dipyridamole; systemic

2.9

42.4

268

943

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

26.6

41.9

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.7

41.8

193

539

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

12.4

41.7

C07AB07

ATC

bisoprolol; oral

1.4

41.3

2841

22846

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.8

41.1

180

481

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

41.1

953

5944

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

39.6

40.6

WX872

NOMESCO Finland

Intensive care

2.5

40.4

329

1347

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

40.0

524

2683

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

39.6

506

2560

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

+∞

39.6

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

11.3

39.5

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.4

38.9

105

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

38.7

1538

11001

C07AB02

ATC

metoprolol; systemic

1.6

38.7

1292

8868

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

13.9

38.2

GBB00

NOMESCO Finland

Tracheostomy

5.7

37.6

111

198

C10AA01

ATC

simvastatin; oral

1.4

37.5

2619

20981

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

37.0

2524

20115

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

10.1

36.8

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

191.0

36.8

G91.1

ICD-10 Finland

Obstructive hydrocephalus

13.1

36.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

36.3

308

1288

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

35.9

359

1630

C09AA02

ATC

enalapril; systemic

1.6

35.3

1211

8344

A28

ICPC

Limited function/disability NOS

1.7

35.3

880

5583

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

35.2

937

6052

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

35.0

1363

9670

WX730

NOMESCO Finland

Conventional respirator

4.5

34.9

128

291

G40.10

ICD-10 Finland

Simple partial seizures

7.8

34.7

105

Z3231

NOMESCO Finland

Registered nurse

1.5

33.8

1535

11248

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

175.9

33.7

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.8

33.5

146

390

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

8.9

33.4

43098

ICD-8 Finland

Subarachnoid haemorrhage, Alia definita, hypertonia non indicata

+∞

33.4

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

33.2

307

1342

N06AB04

ATC

citalopram; systemic

1.5

33.1

1202

8377

R1260

NOMESCO Finland

Evaluation of communicative skills

4.8

32.9

111

232

S06.3

ICD-10 Finland

Focal brain injury

5.0

32.5

107

218

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

32.3

364

1745

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

+∞

32.3

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

32.3

W19

ICD-10 Finland

Unspecified fall

1.9

32.2

522

2891

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.3

32.0

100

192

R4130

NOMESCO Finland

Speech therapy

4.1

31.0

123

302

WX892

NOMESCO Finland

Monitored bed care

2.0

31.0

414

2130

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

30.8

445

2361

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

110.5

30.7

I67.2

ICD-10 Finland

Cerebral atherosclerosis

46.5

30.6

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

30.5

133

356

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

+∞

30.2

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

+∞

30.2

I61

ICD-10 Finland

Intracerebral haemorrhage

+∞

30.2

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

13.8

30.2

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

38.2

30.2

AAK00

NOMESCO Finland

Cranioplasty

38.2

30.2

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.5

30.2

164

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

58.6

30.1

B01AA03

ATC

warfarin; systemic

1.5

29.8

1121

7853

R55

ICD-10 Finland

Syncope and collapse

1.7

29.8

603

3589

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

83.0

29.7

AAK80

NOMESCO Finland

Partial excision of skull cap

155.7

29.7

M03BX01

ATC

baclofen; systemic

4.0

29.4

122

313

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

29.4

347

1697

ICD-10 Finland

2.9

29.3

185

649

NK6AI

NOMESCO Finland

Other cone beam scan

50.2

29.3

Z2446

NOMESCO Finland

Social worker

2.1

29.0

342

1672

Z3226

NOMESCO Finland

Physiotherapist

1.5

29.0

1003

6890

AAF15

NOMESCO Finland

Ventriculoatrial shunt

15.3

28.5

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

15.3

28.5

S06.0

ICD-10 Finland

Concussion

1.8

28.3

534

3109

PA6AD

NOMESCO Finland

CT of neck arteries

5.9

28.2

137

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

18.8

28.2

4301A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]

+∞

28.1

I72.0

ICD-10 Finland

Aneurysm and dissection of carotid artery

18.0

27.8

C09AA05

ATC

ramipril; oral

1.4

27.8

1382

10248

ZXY02

NOMESCO Finland

Neuropsychologist

10.1

27.6

SPAT1229

SPAT

Assessment of need for aid

1.8

27.6

472

2659

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

27.4

394

2086

N28

ICPC

Limited function/disability (N)

4.1

27.3

109

270

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

27.3

522

3047

WW200

SPAT

1.7

27.3

568

3404

N05AH04

ATC

quetiapine; oral

1.6

27.3

800

5276

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

27.2

366

1890

43009

ICD-8 Finland

Subarachnoid haemorrhage, NUD, cum hypertonia

+∞

27.1

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

26.8

333

1663

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

272.1

26.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

26.7

559

3360

N06AB10

ATC

escitalopram; oral

1.5

26.5

951

6576

G40

ICD-10 Finland

Epilepsy

6.5

26.3

107

SPAT1216

SPAT

Assessment of functional ability

1.5

26.0

870

5918

N06AX11

ATC

mirtazapine; oral

1.4

25.9

1703

13261

R53

ICD-10 Finland

Malaise and fatigue

1.5

25.9

1062

7558

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

25.7

228

976

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

25.4

246

1101

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

25.2

1092

7854

R41.0

ICD-10 Finland

Disorientation, unspecified

2.7

25.2

179

680

315

Kela drug reimbursment

Clopidogrel

5.8

24.5

122

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.2

24.2

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

24.0

159

579

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

24.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

23.7

933

6567

AA1AA

NOMESCO Finland

Head X-ray examination

5.0

23.4

154

N05BA04

ATC

oxazepam; oral

1.4

23.3

1321

9995

N05BA01

ATC

diazepam; systemic, rectal

1.6

23.1

734

4922

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

+∞

22.9

43091

ICD-8 Finland

Subarachnoid haemorrhage, Postaneyrisma arteriovenosum, hypertonia non indicata

+∞

22.9

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

14.7

22.9

PA2BM

NOMESCO Finland

MRI examination of vessels in the head with 3 Tesla magnet

25.9

22.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

22.6

696

4634

N05BA09

ATC

clobazam; oral

9.8

22.5

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

22.4

253

1216

N02AX02

ATC

tramadol; systemic, rectal

1.3

22.3

2367

19755

C09CA06

ATC

candesartan; oral

1.4

22.2

1158

8615

P20

ICPC

Memory disturbance

1.6

22.2

668

4421

SPAT1252

SPAT

Overall medication plan or its review

1.8

22.1

401

2300

N06AA09

ATC

amitriptyline; systemic

1.6

22.1

564

3578

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

22.0

545

3430

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

9.8

22.0

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

+∞

21.9

PA7KT

NOMESCO Finland

Temporary closure of brain artery

+∞

21.9

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

29.1

21.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

21.7

604

3918

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

80.4

21.7

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

7.3

21.6

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

8.3

21.3

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

50.1

21.1

A06AD11

ATC

lactulose; oral

1.5

21.1

800

5580

183

Kela drug reimbursment

Lamotrigin and topiramate

5.4

21.0

117

N07BA03

ATC

varenicline; oral

2.1

21.0

254

1256

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

20.9

815

5714

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

20.7

320

1738

2132

FHL

Ventricular operators sunt

77.0

20.7

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

77.0

20.7

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.2

20.6

124

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

20.5

460

2815

N03AX09

ATC

lamotrigine; oral

2.2

20.5

209

959

N01

ICPC

Headache

1.7

20.4

412

2444

G45.3

ICD-10 Finland

Amaurosis fugax

3.1

20.2

110

354

C03CA01

ATC

furosemide; systemic

1.3

20.2

1621

12944

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.0

20.1

116

387

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

20.1

215

1011

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

8.6

20.0

G91.8

ICD-10 Finland

Other hydrocephalus

23.4

19.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

19.7

665

4517

C09CA01

ATC

losartan; oral

1.4

19.6

1321

10249

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.6

19.6

149

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

19.6

204

948

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

19.4

205

958

N05CF01

ATC

zopiclone; oral

1.3

19.4

1807

14731

C09BA02

ATC

enalapril and diuretics; systemic

1.6

19.3

476

2990

N03AE01

ATC

clonazepam; systemic

1.9

19.2

308

1696

R4110

NOMESCO Finland

Physiotherapy

1.4

19.1

1368

10710

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

26.1

19.1

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

26.1

19.1

ZXA00

NOMESCO Finland

Right side

1.3

18.9

1507

11998

G81.1

ICD-10 Finland

Spastic hemiplegia

55.1

18.9

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

18.8

365

2139

Z00.0

ICD-10 Finland

General medical examination

1.4

18.8

944

6953

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

+∞

18.8

G942, I602

ICD-10 Finland

+∞

18.8

C02AC05

ATC

moxonidine; oral

2.0

18.7

254

1315

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.5

18.6

148

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

18.6

153

635

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

190.5

18.5

SPAT1254

SPAT

Administration of medicine

1.5

18.5

743

5239

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

8.7

18.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

18.3

1595

12863

N06AX16

ATC

venlafaxine; oral

1.5

18.2

621

4224

C08CA13

ATC

lercanidipine; oral

1.5

17.8

724

5114

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.8

17.7

199

4308X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS ALIA DEFINITA]

+∞

17.7

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

17.7

N30.0

ICD-10 Finland

Acute cystitis

1.5

17.6

687

4811

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

17.6

369

2215

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

17.3

398

2449

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.0

17.3

328

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

20.9

17.3

S01.0

ICD-10 Finland

Open wound of scalp

1.7

17.2

374

2267

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

17.2

903

6694

Z82.3

ICD-10 Finland

Family history of stroke

10.4

17.1

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

12.5

17.1

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

17.0

1013

7680

G44.8

ICD-10 Finland

Other specified headache syndromes

3.7

16.9

197

C08CA02

ATC

felodipine; oral

1.5

16.9

527

3509

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

16.7

282

1581

R50.9

ICD-10 Finland

Fever, unspecified

1.5

16.6

656

4603

L28

ICPC

Limited function/disability (L)

1.4

16.6

813

5954

N88

ICPC

Epilepsy

5.9

16.6

I63

ICD-10 Finland

Cerebral infarction

13.4

16.4

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

11.2

16.2

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

15.8

286

1643

C08CA05

ATC

nifedipine; systemic

1.7

15.8

346

2104

SPAT1301

SPAT

No procedures

1.3

15.7

1670

13781

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

15.7

251

1381

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

15.7

150

671

WX704

NOMESCO Finland

Intubation

1.7

15.6

360

2220

2164

FHL

Crotigree

+∞

15.6

N03AX16

ATC

pregabalin; oral

1.3

15.4

1223

9690

SPAT1234

SPAT

Support of social functional capacity

1.8

15.4

266

1506

N03AX12

ATC

gabapentin; oral

1.4

15.4

780

5744

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.6

15.3

194

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

15.2

121

493

N02AA05

ATC

oxycodone; systemic

1.4

15.2

756

5545

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

15.1

1512

12368

S02.11

ICD-10 Finland

Fracture of base of skull, open

7.5

15.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

15.0

434

2835

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

15.0

2440

21179

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

31.7

14.8

R11

ICD-10 Finland

Nausea and vomiting

1.6

14.8

380

2413

RP120

NOMESCO Finland

56.8

14.8

XX3XW

NOMESCO Finland

5.3

14.7

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.6

14.7

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.6

1507

12369

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

+∞

14.6

AAC10

NOMESCO Finland

Reinforcement of intracranial aneurysm wall

+∞

14.6

AAC20

NOMESCO Finland

Anastomosis to intracranial vessel

+∞

14.6

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

80.3

14.6

G40.89

ICD-10 Finland

Other epilepsy

6.4

14.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

14.3

523

3607

N03AX18

ATC

lacosamide; systemic

5.1

14.3

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.8

14.3

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

8.2

14.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

14.2

319

1953

J01EA01

ATC

trimethoprim; systemic

1.3

14.2

1322

10700

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.7

14.2

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

14.1

203

A02BC03

ATC

lansoprazole; oral

1.3

14.1

1590

13191

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

13.9

346

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

13.9

1079

8503

RS221

NOMESCO Finland

3.0

13.8

271

Z71.8

ICD-10 Finland

Other specified counselling

1.3

13.8

1095

8659

A02BC01

ATC

omeprazole; systemic

1.3

13.7

1485

12243

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

13.7

681

4994

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

12.0

13.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

13.5

182

944

4319X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]

+∞

13.5

ZYC01

SPAT

1.7

13.3

253

1477

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

13.3

516

3605

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

13.3

250

3915

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.7

13.2

151

Z72.0

ICD-10 Finland

Tobacco use

2.3

13.1

120

529

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

12.9

1235

10015

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

12.9

379

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

12.8

208

1154

RS313

NOMESCO Finland

7.7

12.8

74789

ICD-8 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

50.1

12.8

S06.2

ICD-10 Finland

Diffuse brain injury

3.4

12.8

176

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

12.7

1027

8131

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

12.5

2048

17689

P15

ICPC

Chronic alcohol abuse

2.3

12.5

118

527

4331A

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]

+∞

12.5

43008

ICD-8 Finland

Subarachnoid haemorrhage, Alii definiti, cum hypertonia

+∞

12.5

4311A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]

+∞

12.5

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

+∞

12.5

R13

ICD-10 Finland

Dysphagia

1.6

12.5

310

1952

H47.2

ICD-10 Finland

Optic atrophy

5.2

12.3

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

12.3

119

538

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.2

3429

31249

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

12.2

854

6618

N29

ICPC

Neurological sympt/complt other

2.4

12.2

411

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

37.6

12.2

C03AA03

ATC

hydrochlorothiazide; oral

1.4

12.1

516

3672

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

12.1

2008

17356

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

12.1

1626

18959

SPAT1251

SPAT

Organisation of medication

1.9

12.1

186

1014

N05AX08

ATC

risperidone; systemic

1.5

11.9

366

2429

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

11.9

334

I72.8

ICD-10 Finland

Aneurysm and dissection of other specified arteries

5.5

11.9

D21

ICPC

Swallowing problem

3.1

11.9

209

H34.1

ICD-10 Finland

Central retinal artery occlusion

4.8

11.8

XA400

NOMESCO Finland

EEG

4.8

11.8

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.1

11.8

124

583

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

7.0

11.8

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

11.7

113

511

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

11.7

372

2489

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.1

11.6

108

R51.81

ICD-10 Finland

Facial pain NOS

2.3

11.6

109

485

J01MA02

ATC

ciprofloxacin; systemic

1.2

11.6

2051

17830

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

11.5

103

448

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

11.5

866

6782

C02EA02

ATC

1.7

11.5

229

1358

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

11.5

1446

12105

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.5

309

1987

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

11.5

352

2337

SPAT1240

SPAT

Therapeutic discussion

1.5

11.5

393

2674

I67.5

ICD-10 Finland

Moyamoya disease

+∞

11.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

11.5

529

3823

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.7

11.4

296

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

11.4

462

3256

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.9

11.3

152

791

AN1

Coronary angiography

1.4

11.3

598

4429

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

11.3

616

4584

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

11.3

516

3723

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

11.3

379

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

6.5

11.2

C10AX09

ATC

ezetimibe; oral

1.4

11.2

506

3642

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.0

11.1

202

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

11.1

501

3603

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.6

11.1

138

SPAT1101

SPAT

Orthostatic test

1.7

11.1

228

1365

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.9

11.1

156

827

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

8.0

11.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

11.0

240

1462

A98

ICPC

Health maint/preventive medicine

0.8

11.0

5312

55149

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

11.0

316

2066

N07BB01

ATC

disulfiram; oral

1.8

11.0

177

982

Z43.0

ICD-10 Finland

Attention to tracheostomy

13.9

10.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

10.9

1107

9027

Z50.5

ICD-10 Finland

Speech therapy

3.0

10.9

200

SPAT1053

SPAT

Memory test

1.3

10.8

774

6017

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

10.8

121

586

N03AX11

ATC

topiramate; oral

2.2

10.7

106

486

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.6

10.7

127

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

10.7

921

7349

R60.0

ICD-10 Finland

Localized oedema

1.4

10.7

537

3939

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.8

10.7

231

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

10.6

103

469

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

7.5

10.6

M01AH05

ATC

etoricoxib; oral

0.8

10.6

2591

28679

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

10.6

158

855

A11CC03

ATC

alfacalcidol; systemic

2.1

10.6

113

539

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

10.5

317

2095

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

110.2

10.4

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

110.2

10.4

4331X

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]

+∞

10.4

4360A

ICD-9 Finland

Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]

+∞

10.4

G942, I601

ICD-10 Finland

+∞

10.4

A12BA01

ATC

potassium chloride; oral

1.6

10.3

238

1474

S06.4

ICD-10 Finland

Epidural haemorrhage

7.1

10.2

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

10.0

671

5162

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

4.0

10.0

R40.2

ICD-10 Finland

Coma, unspecified

3.2

10.0

162

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5.1

10.0

B01AC22

ATC

prasugrel; oral

4.6

10.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

9.9

537

3996

R06.0

ICD-10 Finland

Dyspnoea

1.2

9.9

1210

10080

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.6

9.8

255

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

9.8

1688

14575

W06

ICD-10 Finland

Fall involving bed

3.4

9.8

137

AA9PW

NOMESCO Finland

26.0

9.8

N05CD07

ATC

temazepam; oral

1.3

9.8

643

4928

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

9.8

1114

9202

127

Kela drug reimbursment

Transplant complication

2.5

9.7

300

N06AX21

ATC

duloxetine; oral

1.4

9.7

475

3469

GBB03

NOMESCO Finland

Percutaneous tracheostomy

13.4

9.6

A04

ICPC

Weakness/tiredness general

1.4

9.6

578

4371

G93.90

ICD-10 Finland

Brain death

55.1

9.6

2102

FHL

Exploratory craniotomy and / or cranectomy

55.1

9.6

C07AG02

ATC

carvedilol; oral

1.5

9.6

293

1945

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

9.6

174

1004

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

9.6

222

1374

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.5

9.6

303

EBA00

NOMESCO Finland

Extraction of tooth

1.2

9.6

1519

13007

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

9.5

507

3759

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

9.5

102

487

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

9.4

298

1995

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

9.4

4310A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]

+∞

9.4

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.3

9.4

137

S06.9

ICD-10 Finland

Intracranial injury, unspecified

4.0

9.3

A01

ICPC

Pain general/multiple sites

1.5

9.3

346

2401

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

9.3

112

N80

ICPC

Head injury other

2.5

9.2

283

H02AB06

ATC

prednisolone; systemic

1.2

9.2

2446

21962

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

5.2

9.2

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5.4

9.2

L04AA06

ATC

mycophenolic acid; systemic

2.3

9.1

344

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

9.1

242

1556

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.3

9.0

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

9.0

145

809

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

3.5

9.0

115

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

8.9

351

M79.6

ICD-10 Finland

Pain in limb

1.2

8.9

1743

15212

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

8.9

470

3480

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

24.0

8.9

G44.0

ICD-10 Finland

Cluster headache syndrome

2.9

8.9

174

F80.1

ICD-10 Finland

Expressive language disorder

4.2

8.8

M54.5

ICD-10 Finland

Low back pain

1.2

8.8

1572

13602

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

8.8

187

1136

H35.6

ICD-10 Finland

Retinal haemorrhage

3.3

8.8

123

R52.2

ICD-10 Finland

Other chronic pain

1.8

8.7

146

823

SPAT1210

SPAT

Application of cast or individual aid

1.6

8.7

195

1202

2127

FHL

Ventriculostomy

50.0

8.7

J67.1

ICD-10 Finland

Bagassosis

50.0

8.7

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

8.6

257

1703

C01DA14

ATC

isosorbide mononitrate; oral

1.3

8.6

761

6088

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

8.6

686

5410

7803A

ICD-9 Finland

General symptoms, Convulsions

3.2

8.6

136

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

2.4

8.5

279

ZXD00

NOMESCO Finland

Emergency procedure

1.8

8.5

142

801

G43.8

ICD-10 Finland

Other migraine

2.8

8.5

188

Q28.0

ICD-10 Finland

Arteriovenous malformation of precerebral vessels

27.5

8.5

3314A

ICD-9 Finland

Other cerebral degenerations, Obstructive hydrocephalus

20.0

8.5

R41.3

ICD-10 Finland

Other amnesia

1.9

8.5

121

650

C09DA06

ATC

candesartan and diuretics; oral

1.4

8.4

352

2500

G03.9

ICD-10 Finland

Meningitis, unspecified

5.3

8.4

I66.9

ICD-10 Finland

Occlusion and stenosis of unspecified cerebral artery

90.1

8.4

44209

ICD-8 Finland

Other aneurysm, Ruptura non indicata

90.1

8.4

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

5.6

8.4

R04.0

ICD-10 Finland

Epistaxis

1.4

8.4

333

2340

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

8.4

122

659

R03BB04

ATC

tiotropium bromide; inhalant

1.4

8.4

484

3639

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.3

8.4

306

H34.2

ICD-10 Finland

Other retinal artery occlusions

4.2

8.3

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

4.8

8.3

I65.1

ICD-10 Finland

Occlusion and stenosis of basilar artery

+∞

8.3

PA7YT

NOMESCO Finland

Very extensive carotis artery PTA with stent

+∞

8.3

PCU93

NOMESCO Finland

Injection of therapeutic or sclerosing agent into bypass from suprarenal abdominal aorta and visceral arteries

+∞

8.3

2162

FHL

Wall reinforcement, big brain

+∞

8.3

AAC99

NOMESCO Finland

Other operation for aneurysm or other intracranial vascular lesion

+∞

8.3

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

8.3

113

596

ZXH06

SPAT

1.9

8.2

115

612

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.8

8.2

142

813

ZX122

NOMESCO Finland

Intra-arterial

4.7

8.2

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

8.2

1036

8645

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

8.2

257

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

7.5

8.1

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

8.1

393

2868

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.3

8.1

120

C10AA04

ATC

fluvastatin; oral

1.4

8.1

422

3121

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

33.4

8.1

C07AB03

ATC

atenolol; systemic

1.5

8.1

295

2043

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

17.2

8.1

SPAT1284

SPAT

Extensive health certificate

1.8

8.0

123

676

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

8.0

262

1768

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

5.2

8.0

RS340

NOMESCO Finland

5.8

8.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

8.0

242

1609

H93.1

ICD-10 Finland

Tinnitus

1.5

7.9

294

2041

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.2

7.9

337

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

7.8

396

TK800

NOMESCO Finland

Hemodialysis

2.0

7.8

481

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

7.8

330

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.9

7.8

155

XX4BW

NOMESCO Finland

8.4

7.8

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

8.4

7.8

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.6

7.8

198

1261

79199

ICD-8 Finland

Headache

2.2

7.8

344

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

7.7

302

2116

WW806

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by doctor

45.0

7.7

XA800

SPAT

45.0

7.7

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

7.7

406

A12AA04

ATC

calcium carbonate; oral

2.2

7.7

348

OAB43

SPAT

0.7

7.7

299

4085

SPAT1243

SPAT

Psychiatric/psychological examination

2.1

7.6

398

PA1AC

NOMESCO Finland

Aortocervical angiongraphy with X-ray

25.0

7.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

7.6

202

1303

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.1

7.5

393

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

7.4

631

5018

I65.9

ICD-10 Finland

Occlusion and stenosis of unspecified precerebral artery

80.2

7.4

PA2PT

NOMESCO Finland

Permanent closure of brain artery

80.2

7.4

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

7.4

260

RS222

NOMESCO Finland

2.4

7.4

260

N17

ICPC

Vertigo/dizziness

1.3

7.3

483

3707

C08DB01

ATC

diltiazem; oral

1.5

7.3

258

1771

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

7.3

198

1283

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.0

7.3

136

4341A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral embolism

+∞

7.3

G942, I690

ICD-10 Finland

+∞

7.3

AAL20

NOMESCO Finland

Endovascular occlusion of intracranial arterio-venous malformation

+∞

7.3

I67

ICD-10 Finland

Other cerebrovascular diseases

+∞

7.3

4349A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]

+∞

7.3

G942, I600

ICD-10 Finland

+∞

7.3

G942, I609

ICD-10 Finland

+∞

7.3

CEC30

NOMESCO Finland

Resection of extraocular muscle

10.8

7.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.3

1982

17741

J01DB01

ATC

cefalexin; oral

1.2

7.3

4524

43093

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

6.8

7.3

5541

FHL

Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery

15.7

7.2

G30.8

ICD-10 Finland

Other Alzheimer disease

2.0

7.2

448

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.2

7.2

K89

ICPC

Transient cerebral ischaemia

2.8

7.2

148

F06.7

ICD-10 Finland

Mild cognitive disorder

1.8

7.2

119

672

H02AB04

ATC

methylprednisolone; systemic

1.3

7.1

697

5640

G81.0

ICD-10 Finland

Flaccid hemiplegia

30.0

7.1

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

7.1

159

979

C09CA03

ATC

valsartan; oral

1.4

7.1

410

3081

G46.4

ICD-10 Finland

Cerebellar stroke syndrome

20.0

7.1

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

7.1

177

1125

M05BA04

ATC

alendronic acid; oral

1.3

7.1

424

3205

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

7.1

142

ZXA05

NOMESCO Finland

Left side

1.2

7.1

1296

11205

XX7FW

NOMESCO Finland

6.5

7.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

7.1

417

3145

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

12.0

7.1

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

7.1

140

837

R07.3

ICD-10 Finland

Other chest pain

1.3

7.1

414

3123

N06AB06

ATC

sertraline; oral

1.3

7.0

423

3202

C08DA01

ATC

verapamil; systemic

1.6

7.0

184

1182

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.6

7.0

181

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.5

7.0

199

K08.3

ICD-10 Finland

Retained dental root

1.4

6.9

294

2098

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.4

6.9

266

1864

Z03

ICPC

Housing/neighbourhood problem

3.3

6.9

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.3

6.9

269

C07AB05

ATC

betaxolol; oral

1.7

6.9

128

751

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

6.9

124

719

RS230

NOMESCO Finland

3.5

6.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

6.8

166

1048

PEC23

NOMESCO Finland

Suture of common femoral artery

4.4

6.8

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

5.0

6.8

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

6.8

157

979

RT152

NOMESCO Finland

40.1

6.8

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.3

6.7

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

16.7

6.7

Angiography of the heart and coronary arteries

1.4

6.7

294

2109

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.0

6.7

419

40199

ICD-8 Finland

Essential benign hypertension

1.9

6.7

533

P29

ICPC

Psychological sympt/compl other

1.6

6.7

180

1166

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

22.5

6.7

RT162

NOMESCO Finland

22.5

6.7

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.7

570

4537

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.1

6.7

111

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

6.6

255

1786

SPAT1285

SPAT

Provision of consultation response

1.5

6.6

235

1621

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

6.6

1321

11506

G43.3

ICD-10 Finland

Complicated migraine

2.3

6.6

232

I77.0

ICD-10 Finland

Arteriovenous fistula, acquired

5.9

6.6

WX320

NOMESCO Finland

Spinalanesthesy

0.8

6.6

810

9610

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.4

6.6

260

1834

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

6.6

331

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.6

6.6

174

1125

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

6.5

730

5999

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

8.7

6.5

280

Kela drug reimbursment

Clopidogrel

2.1

6.5

320

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

6.5

117

680

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.5

6.5

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

6.5

211

1430

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

6.5

348

J46

ICD-10 Finland

Status asthmaticus

1.7

6.5

120

704

S02.10

ICD-10 Finland

Fracture of base of skull, closed

3.6

6.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

6.4

278

1993

N06AX03

ATC

mianserin; oral

1.5

6.4

212

1437

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.4

6.4

201

G41.0

ICD-10 Finland

Grand mal status epilepticus

5.7

6.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

6.4

336

2490

7478X

ICD-9 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

69.9

6.4

C02DE03

ATC

69.9

6.4

PA2AM

NOMESCO Finland

Simple MRI examination of vessels in the head with 3 Tesla magnet

69.9

6.4

PA2CM

NOMESCO Finland

Extensive MRI examination of vessels in the head with 3 Tesla magnet

69.9

6.4

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.0

6.4

390

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.4

1049

8973

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.4

6.4

253

1783

OAB42

SPAT

1.5

6.4

186

1231

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

6.4

791

6580

P70

ICPC

Dementia

1.9

6.3

478

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

6.3

333

2472

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.3

144

895

PA6CM

NOMESCO Finland

Extensive MRI examination of neck vasculature with 3 Tesla magnet

11.0

6.3

RS314

NOMESCO Finland

5.9

6.3

3643

FHL

Vitrectomy through pars Plana

5.5

6.3

KHV

NOMESCO Finland

2.6

6.3

163

PA2BT

NOMESCO Finland

Cerebral artery extensive PTA

+∞

6.2

PA2AT

NOMESCO Finland

Cerebral artery PTA

+∞

6.2

G942, I615

ICD-10 Finland

+∞

6.2

G942, I606

ICD-10 Finland

+∞

6.2

PA1CC

NOMESCO Finland

Extensive aortocervical angiongraphy with X-ray (including 3 to 4 selective injections)

+∞

6.2

I66.0

ICD-10 Finland

Occlusion and stenosis of middle cerebral artery

+∞

6.2

Y3090

ICD-8 Finland

+∞

6.2

PA2CT

NOMESCO Finland

Cerebral artery very extensive PTA

+∞

6.2

2163

FHL

Proxies. Vascular ligation, big brain

+∞

6.2

A46

ICD-10 Finland

Erysipelas

1.3

6.2

644

5249

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

6.2

219

N99

ICPC

Neurological disease other

2.3

6.2

219

AXX01

SPAT

2.1

6.2

305

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.4

6.2

201

K87

ICPC

Hypertension complicated

1.8

6.2

101

570

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.2

260

1855

RF120

NOMESCO Finland

2.2

6.2

252

S06.8

ICD-10 Finland

Other intracranial injuries

5.7

6.1

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.8

6.1

479

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

6.1

247

1749

C02DE04

ATC

1.7

6.1

124

751

J01FA06

ATC

roxithromycin; oral

1.2

6.1

2040

18494

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.1

6.1

323

SPAT1050

SPAT

Extensive neurological examination

1.8

6.1

531

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.1

1541

13684

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

6.1

471

3703

S09.9

ICD-10 Finland

Unspecified injury of head

2.3

6.0

224

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

6.0

113

668

K92.1

ICD-10 Finland

Melaena

1.5

6.0

214

1479

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003396) Base excess in Arterial blood by calculation

1664

6491

3.05

307.95

8.4

7.0

mmol/l

1.1

0.08

1295

5039

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

428

283

16.04

307.65

1.7

1.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1667

6516

3.04

307.33

8.4

6.9

kpa

5.1

0.48

1602

6193

(3027801) Oxygen [Partial pressure] in Arterial blood

1666

6514

3.04

306.95

8.4

6.9

kpa

13.8

12.3

16.18

1599

6185

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1774

7657

2.76

267.96

2.0

1.9

29.0

30.0

8.77

1724

7410

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

320

416

8.01

231.57

3.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2887

16504

2.27

229.99

2.5

2.0

u/l

242.3

208.7

0.42

2760

15273

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

486

1006

5.12

221.40

2.5

1.3

e6/l

59.2

23.5

3.19

404

771

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

486

1006

5.12

221.40

2.5

1.3

e6/l

12171.9

841.8

4.40

415

818

(3044290) Cell count panel - Cerebral spinal fluid

438

913

5.05

197.59

2.6

1.2

—

(3016502) Oxygen saturation in Arterial blood

1332

5859

2.57

186.63

9.6

7.3

96.0

95.6

0.93

1285

5616

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1258

5386

2.63

186.33

10.0

7.7

g/l

122.3

120.4

2.69

1220

5171

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

486

1171

4.38

183.26

1.9

1.2

mg/l

758.9

537.2

1.64

466

1101

(3043409) Potassium [Moles/volume] in Arterial blood

584

1704

3.65

168.40

7.3

3.8

mmol/l

3.8

3.9

2.28

571

1599

(3014576) Chloride [Moles/volume] in Serum or Plasma

1458

7140

2.31

158.59

7.5

6.8

mmol/l

104.8

104.4

2.30

1433

6980

(3019060) Gas panel - Arterial blood

955

3842

2.72

158.47

7.9

4.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

918

3645

2.75

156.15

12.0

6.6

mmol/l

24.9

24.6

1.28

869

3380

(3020891) Body temperature

673

2291

3.14

151.26

7.5

4.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

766

2914

2.83

140.73

8.2

9.1

mmol/l

24.1

24.3

1.09

734

2700

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

389

1026

3.95

129.21

1.7

1.2

mmol/l

3.7

3.8

0.85

361

955

(3016018) Differential panel - Cerebral spinal fluid

246

479

5.29

119.46

3.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1051

5010

2.29

118.82

6.6

7.1

mmol/l

8.1

10.4

20.05

987

4765

(3013826) Glucose [Moles/volume] in Serum or Plasma

4365

33457

1.80

118.15

7.3

4.5

mmol/l

6.8

6.7

0.12

4155

31301

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

161

224

7.33

109.47

4.2

1.2

—

(3023410) Appearance of Cerebral spinal fluid

218

414

5.40

108.81

3.2

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

2170

13973

1.80

102.80

4.6

3.8

92.0

89.7

3.86

2102

13613

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

994

5015

2.14

96.25

2.7

2.3

ug/l

5.6

7.3

1.67

877

4310

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

726

3289

2.35

91.11

8.1

7.0

mmol/l

24.2

24.9

6.70

716

3262

(3032080) INR in Blood by Coagulation assay

3193

23451

1.66

90.70

9.4

9.0

inr

1.2

1.3

1.21

845

6567

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1293

7338

1.93

89.79

6.3

5.6

mmol/l

1.0

2.19

1202

6790

(40761535) Cells panel - Urine sediment

950

4835

2.12

89.49

4.2

3.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1532

9229

1.84

88.21

3.2

mmol/l

0.8

4.12

1421

8575

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3508

26552

1.64

87.26

8.4

5.8

mmol/l

1.2

50.10

3264

23881

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

25.21

85.62

2.3

1.2

52.4

21.4

2.28

(3036489) Thrombin time

437

1600

2.85

85.06

2.1

1.9

20.3

21.8

7.36

400

1389

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

176

355

5.06

82.03

2.1

1.2

mmol/l

2.7

2.1

3.85

160

334

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1260

7438

1.85

76.16

9.1

7.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1962

13170

1.68

75.47

4.5

3.7

—

(3019150) Specific gravity of Urine by Refractometry

1842

12176

1.69

75.00

5.0

4.2

kg/l

1.0

0.08

185

1851

(3044640) Blood type and Crossmatch panel - Blood

2519

18033

1.62

74.97

2.6

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

110

155

7.19

73.94

3.5

2.6

umol/l

29.8

28.0

0.73

111

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2970

22235

1.58

72.49

4.3

3.6

ng/l

38.4

86.1

1.44

2258

15506

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

11.48

72.38

2.2

1.2

33.5

65.0

3.85

(3014111) Lactate [Moles/volume] in Serum or Plasma

897

4884

1.96

68.94

7.6

6.7

mmol/l

1.3

1.4

0.22

867

4706

(3000991) Gas panel - Venous blood

857

4603

1.98

68.50

9.1

8.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1991

13688

1.63

68.48

2.5

2.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3706

29463

1.55

67.43

9.0

6.5

mmol/l

1.2

37.77

3283

24708

(3023368) Bacteria identified in Blood by Culture

2193

15818

1.56

59.93

4.4

4.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

116

231

5.09

54.91

1.9

1.3

44.8

59.6

1.22

(3029937) Albumin [Presence] in Urine by Test strip

2078

15069

1.54

54.27

5.0

4.1

estimate

0.0

1.94

490

4950

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

156

6.03

52.96

1.6

1.2

19.3

31.9

0.76

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3296

26548

1.45

49.92

4.3

4.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

166

5.66

49.67

2.2

umol/l

56.0

54.8

0.10

130

(3003181) Sodium [Moles/volume] in Urine

270

1020

2.71

49.27

1.6

1.3

mmol/l

82.9

62.6

7.34

223

809

(3022217) INR in Platelet poor plasma by Coagulation assay

1182

7731

1.64

47.18

24.7

25.0

inr

1.3

1.4

0.14

105

1153

(3026008) Bacteria identified in Urine by Culture

2333

17821

1.46

45.40

3.7

3.2

—

(3015736) pH of Urine

2731

21498

1.44

45.26

4.4

3.5

—

5.7

—

(1761868) Lipid panel - Serum or Plasma

1417

19354

0.66

39.57

3.0

2.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

701

4230

1.73

37.42

3.4

3.0

kpa

4.6

4.5

0.43

678

4089

(3009466) Valproate [Moles/volume] in Serum or Plasma

178

627

2.89

37.10

3.8

5.1

umol/l

357.4

358.1

0.02

147

544

(3024561) Albumin [Mass/volume] in Serum or Plasma

3090

25455

1.38

36.89

5.2

4.8

g/l

34.6

35.3

9.59

2896

23520

(3009542) Hematocrit [Volume Fraction] of Blood

4569

50693

0.72

35.65

21.1

15.6

38.8

39.5

4.57

2988

34854

(4034850)

372

1866

2.05

35.34

12.3

9.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

370

1867

2.04

34.58

2.2

ug/l

523.1

641.5

0.31

351

1758

(3021447) Carbon dioxide [Partial pressure] in Venous blood

811

5191

1.64

34.49

4.2

3.6

kpa

5.8

0.35

788

5034

(3020191) Ethanol [Moles/volume] in Serum or Plasma

122

363

3.40

33.86

1.5

promille

1.3

1.2

0.37

280

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

467

2579

1.87

33.46

2.9

2.6

0.7

1.50

455

2458

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

548

3181

1.78

33.37

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

242

1049

2.35

33.08

2.4

2.9

umol/l

33.2

35.0

0.41

211

884

(3002032) Base excess in Venous blood by calculation

800

5172

1.62

32.57

4.2

3.6

mmol/l

1.9

0.01

669

4176

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

463

2584

1.85

32.07

3.8

3.9

52.8

47.8

3.99

457

2548

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

735

4684

1.64

31.68

2.7

2.6

ml/min/173m2

62.9

64.4

0.45

294

1870

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

7.86

31.46

1.5

4.3

umol/l

43.7

38.0

0.69

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

356

1835

1.99

31.33

3.1

2.8

u/ml

0.3

0.13

209

1002

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1288

9324

1.47

31.07

1.9

1.8

—

(3012544) pH of Venous blood

818

5399

1.58

30.42

4.1

3.6

7.3

7.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

291

1419

2.10

29.82

2.5

2.4

g/l

3.6

0.07

279

1348

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

932

6381

1.53

29.38

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

568

3454

1.70

29.24

3.3

g/l

126.7

128.1

0.74

556

3370

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

521

3124

1.72

28.21

10.9

9.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

283

1403

2.06

27.75

2.3

2.1

96.3

89.9

5.29

270

1312

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

265

1289

2.10

27.34

2.5

2.3

188.2

199.2

1.17

256

1223

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2593

21456

1.33

27.31

4.9

4.0

—

(3035350) Ketones [Presence] in Urine by Test strip

3247

27760

1.32

27.02

4.6

3.7

estimate

0.0

0.80

522

5049

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

919

6396

1.50

26.63

1.8

1.7

—

(3039000) Anion gap in Blood

267

1325

2.06

26.12

11.0

7.0

mmol/l

10.8

11.3

1.15

234

1179

(3018572) Chloride [Moles/volume] in Blood

267

1326

2.05

26.07

11.1

7.0

mmol/l

106.0

105.0

1.80

234

1180

(3027273) Bicarbonate [Moles/volume] in Venous blood

466

2787

1.72

25.43

3.6

3.3

mmol/l

25.3

25.2

0.10

454

2697

(3031040) Bacteria [#/volume] in Urine by Automated count

4226

37667

1.31

24.94

5.5

4.6

e6/l

1458.1

2150.0

0.40

562

(3009261) Glucose [Presence] in Urine by Test strip

3268

28195

1.30

24.47

4.6

3.8

estimate

0.0

0.17

512

4998

(3021601) Nitrite [Presence] in Urine by Test strip

3221

27873

1.29

23.02

5.8

5.0

estimate

0.0

0.80

511

5118

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

413

2455

1.72

23.02

8.3

5.1

1.7

1.6

0.73

378

2290

(3007930) Methemoglobin/Hemoglobin.total in Blood

408

2428

1.72

22.65

8.3

5.1

1.0

0.9

2.01

374

2265

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

4.21

22.51

1.4

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1447

11246

1.36

22.30

1.8

nmol/l

1282.8

1179.7

3.99

1167

8406

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

168

739

2.30

22.30

5.5

6.6

mg/l

11.1

12.1

2.13

158

681

(3051593) INR in Capillary blood by Coagulation assay

167

3.86

21.70

6.5

19.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

901

6563

1.43

20.27

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2199

18375

1.29

19.81

2.8

2.5

u/l

58.8

58.1

0.17

2047

16916

(3047181) Lactate [Moles/volume] in Blood

319

1841

1.77

19.74

10.5

6.1

mmol/l

1.3

0.27

272

1620

(3018418) pH of Serum or Plasma

2100

17452

1.29

19.72

4.7

4.0

7.4

0.85

344

3315

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3432

30429

1.25

18.28

5.8

6.2

umol/l

10.5

11.5

5.48

3267

28839

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

269

2.96

17.70

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

382

2396

1.63

17.36

2.3

1.9

ug/l

2.3

2.5

0.08

321

2131

(3016038) Potassium [Moles/volume] in Urine

377

2.59

16.95

1.2

mmol/l

28.0

35.0

3.02

316

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

253

2.95

16.49

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

314

2.73

16.42

2.2

2.4

umol/l

17.2

24.9

—

(3008295) Osmolality of Serum or Plasma

128

583

2.22

15.76

1.8

1.3

mosm/kgh2o

279.5

277.3

0.42

100

447

(3042936) Bacteria identified in Isolate by Culture

1041

8088

1.34

15.49

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

685

4981

1.42

15.37

2.3

nmol/l

368.6

375.1

0.41

628

4564

(40768804) Tissue Pathology biopsy report

2054

23915

0.80

15.31

2.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

281

1701

1.68

14.70

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1221

9790

1.30

14.41

3.0

2.7

e6/l

1.4

0.00

761

5604

(36304419) Bacteria [Presence] in Urine

1825

15408

1.25

14.04

3.7

3.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5299

55719

0.80

13.53

4.7

4.4

mmol/l

1.4

1.5

14.59

4910

50763

(3030467) Casts [#/volume] in Urine by Automated count

1876

15949

1.24

13.45

3.7

3.1

e6/l

0.4

0.08

1489

11944

(3002385) Erythrocyte distribution width [Ratio]

4314

46303

0.82

13.38

22.7

17.7

13.9

13.8

5.67

4236

45253

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1483

12340

1.26

12.78

1.9

1.7

mg/l

1.3

0.36

1181

9538

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1366

11266

1.26

12.69

4.3

3.7

ng/l

426.1

490.1

0.20

1104

8985

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

574

4194

1.40

12.49

1.8

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5361

56151

0.81

12.09

4.7

4.5

mmol/l

4.5

4.7

40.68

5002

51476

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

131

669

1.98

12.04

1.5

1.2

u/ml

4.8

3.1

0.46

207

(3000850) Epithelial cells [#/volume] in Urine

1452

12155

1.25

11.74

3.1

2.6

e6/l

5.2

5.5

0.45

1302

10594

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

284

4296

0.65

11.56

1.9

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

222

1350

1.67

11.49

1.4

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

651

4963

1.34

10.85

2.1

2.6

g/l

65.9

66.4

0.78

582

4463

(21494755) Public health laboratory ask at order entry panel

283

4224

0.66

10.80

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

371

2577

1.46

10.67

4.8

3.8

mmol/l

24.0

24.2

0.49

328

2295

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2022

17651

1.20

10.66

2.8

3.0

ng/l

1480.6

1481.4

0.00

1770

15181

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1686

14471

1.22

10.58

2.4

2.3

mg/l

3.2

3.0

2.45

1476

12337

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

108

542

2.01

10.48

3.1

3.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

124

653

1.92

10.47

1.5

1.2

u/ml

6.3

3.9

1.06

271

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5137

53844

0.83

10.41

16.6

13.6

ml/min/173m2

79.5

78.0

5.19

4430

44468

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

872

10802

0.78

10.38

2.9

3.1

ug/l

0.8

0.00

590

7335

(3000963) Hemoglobin [Mass/volume] in Blood

6082

62619

0.79

10.08

28.7

21.6

g/l

132.3

134.7

30.21

6011

61610

(3026361) Erythrocytes [#/volume] in Blood

6082

62609

0.79

9.97

28.5

21.4

e12/l

4.4

4.5

33.37

5959

60646

(3024731) MCV [Entitic volume]

6082

62604

0.79

9.91

28.4

21.4

91.6

91.3

5.69

6010

61581

(3010813) Leukocytes [#/volume] in Blood

6084

62621

0.79

9.90

28.5

21.5

e9/l

7.0

6.7

25.12

5963

60639

(3035941) MCH [Entitic mass]

6082

62602

0.79

9.89

28.4

21.3

30.4

2.92

6010

61579

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

412

2.13

9.88

1.0

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

671

5208

1.32

9.87

1.7

1.5

—

(3026782) Osmolality of Urine

1332

11238

1.23

9.81

3.3

2.8

mosm/kgh2o

523.6

543.6

2.80

1156

9537

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

243

1579

1.56

9.64

1.9

1.6

g/l

0.2

0.14

230

1493

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5523

57402

0.82

9.63

5.3

5.0

mmol/l

2.6

2.8

40.51

5138

52347

(3007461) Platelets [#/volume] in Blood

6082

62577

0.79

9.61

28.5

21.5

e9/l

251.7

249.2

2.19

5966

60828

(3010375) cycloSPORINE [Mass/volume] in Blood

228

2.51

9.57

28.7

26.1

ug/l

103.2

111.3

0.52

185

(3002256) Pathology report gross observation

607

7791

0.76

9.44

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1295

10953

1.22

9.26

2.6

3.1

mmol/l

2.5

0.66

1133

9567

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

111

589

1.90

9.22

1.5

1.8

—

(3023419) Bacteria identified in Sputum by Culture

131

735

1.80

9.12

2.0

2.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.94

9.11

1.6

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

245

1632

1.52

8.71

2.0

1.6

g/l

1.2

0.03

231

1544

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

2.90

8.67

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5869

60523

0.82

8.64

11.9

10.6

u/l

25.6

25.9

0.65

5712

58125

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

125

2.97

8.59

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

251

1692

1.50

8.45

3.6

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1570

13639

1.19

8.39

1.6

1.5

nmol/l

19.0

20.5

3.44

1373

11584

(3015377) Calcium [Moles/volume] in Serum or Plasma

2224

20002

1.16

7.69

2.8

3.4

mmol/l

2.4

1.49

1928

17284

(3045716) Anion gap in Serum or Plasma

262

2.22

7.51

2.1

2.3

mmol/l

8.6

9.2

0.46

198

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

219

2.34

7.43

1.7

2.2

umol/l

84.4

152.5

1.40

121

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

136

2.73

7.42

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

109

618

1.78

7.41

1.1

124.3

117.2

1.61

100

547

(46235355) HIV 1 and 2 tests - Meaningful Use set

820

6762

1.24

7.37

1.8

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1950

17428

1.16

7.23

3.8

3.2

e6/l

86.4

96.6

0.09

1545

13343

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

488

1.86

7.10

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

488

1.86

7.10

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

488

1.86

7.10

1.6

1.8

—

(3042733) HLA Ab [Presence] in Serum

157

2.56

7.07

5.0

4.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

113

658

1.73

7.03

4.3

5.5

mmol/l

7.2

7.3

0.01

539

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

468

3625

1.31

7.01

4.5

3.5

kpa

5.2

0.26

426

3329

(3018095) Leukocytes [#/volume] in Urine

2233

20204

1.15

6.97

4.4

3.7

e6/l

78.5

105.0

1.79

1679

14372

(3009445) Proteinase 3 Ab [Units/volume] in Serum

331

2437

1.38

6.96

1.5

1.6

u/ml

3.7

16.9

—

(3009343) pH of Capillary blood

461

3569

1.31

6.93

4.5

3.5

7.4

1.53

442

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

543

1.80

6.91

1.6

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

594

7328

0.79

6.67

4.9

4.5

33.4

32.5

1.08

433

4748

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

708

5810

1.24

6.64

1.9

1.7

1.5

6.58

624

5051

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.34

6.54

4.2

5.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

116

695

1.68

6.54

1.5

1.3

nmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.64

6.46

1.1

—

(4306422)

109

646

1.70

6.40

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

420

1.87

6.33

1.3

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.09

6.30

1.0

1.1

89.0

78.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

127

787

1.62

6.30

1.5

1.3

nmol/l

0.1

0.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

126

780

1.63

6.27

1.5

1.3

nmol/l

0.7

2.6

0.69

119

747

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

6.26

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

441

3444

1.30

6.24

4.4

3.5

mmol/l

1.8

1.9

0.49

327

2570

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

110

659

1.68

6.22

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

567

4574

1.26

6.19

5.0

3.5

ng/l

99.2

89.9

1.35

498

3886

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

132

2.58

6.19

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1362

15420

0.86

6.13

1.6

mmol/l

1.4

1.29

1173

12771

(3024928) Oxygen saturation in Venous blood

171

1142

1.51

6.13

3.1

3.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5198

53812

0.87

6.00

4.3

4.0

mmol/l

1.4

1.3

5.10

4790

48584

(4268621)

458

1.80

5.95

2.7

2.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

200

2836

0.70

5.94

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

135

2.53

5.93

1.1

—

(3010421) pH of Blood

217

1530

1.43

5.92

4.4

7.4

0.25

160

1285

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

114

699

1.64

5.92

1.3

pmol/l

319.3

316.0

0.02

541

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5398

55720

0.87

5.92

4.9

4.7

mmol/l

6.0

0.30

4976

50337

(3001019) Free T4 and TSH panel - Serum or Plasma

164

2406

0.67

5.85

2.1

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

130

2.55

5.85

1.1

95.3

85.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

2.55

5.85

1.1

1.2

98.7

85.9

0.57

(40768446) Kidney Pathology biopsy report

186

2.27

5.78

2.1

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

114

706

1.62

5.71

1.5

1.3

—

(3051651) Icteric interference index of Serum or Plasma

301

1.97

5.66

2.9

3.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.70

5.63

2.0

1.1

18.4

20.0

—

(3011985) Renin [Units/volume] in Plasma

118

741

1.60

5.59

1.3

1.4

mu/l

66.4

55.3

0.34

107

660

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1686

18681

0.87

5.56

4.6

5.1

ug/l

5.4

3.5

0.27

1524

16708

(3000330) Specific gravity of Urine by Test strip

224

3078

0.72

5.55

4.1

3.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

256

2.04

5.51

2.6

2.4

94.4

93.6

0.05

243

(3006653) Thiamine [Moles/volume] in Blood

263

2.02

5.50

1.2

nmol/l

139.2

133.6

0.27

263

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

256

1896

1.36

5.28

1.7

1.6

titre

111.7

269.0

1.72

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

303

1.92

5.23

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

700

5883

1.21

5.23

1.7

1.5

—

(3013512) EKG study

1581

17527

0.87

5.20

4.2

4.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

218

1577

1.39

5.19

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

205

1468

1.41

5.18

3.2

3.0

mmol/l

24.7

25.0

0.58

173

1267

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

236

2.04

5.13

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

427

3411

1.27

5.10

1.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

507

4134

1.24

5.08

2.0

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

218

1584

1.39

5.07

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

552

1.66

4.99

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

288

1.92

4.94

1.0

1.1

nmol/l

3.6

12.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

131

869

1.52

4.93

1.6

1.4

u/ml

117.9

118.7

0.03

191

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

205

1482

1.39

4.92

1.5

—

(4198724)

136

2.36

4.89

1.5

1.6

—

(3025941) Bacteria identified in Stool by Culture

383

3038

1.28

4.86

1.3

1.2

—

(3044889) 12 lead EKG panel

4291

41024

1.12

4.85

4.2

3.8

—

(40768800) Prostate Pathology biopsy report

1234

0.60

4.78

1.2

—

(3024316) Viscosity of Plasma

4.59

4.78

1.1

1.6

mpas

1.4

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.88

4.75

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

177

1256

1.42

4.74

3.5

2.8

kpa

8.2

8.0

1.10

159

1161

(3021901) Oxygen saturation in Capillary blood

154

1065

1.46

4.74

3.0

2.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

343

1.81

4.72

1.1

mg/l

46.0

43.8

0.12

287

(3024471) HLA-A [Type]

164

2.20

4.70

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

137

929

1.48

4.66

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

281

2154

1.32

4.64

1.3

1.2

u/ml

0.9

1.1

0.20

208

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

212

1563

1.37

4.55

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

213

2.03

4.55

1.0

1.1

—

(4027681)

248

1.94

4.52

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

255

1.93

4.52

1.2

1.1

ratio

1.1

1.0

1.30

(3024932) HLA-DR beta [Type]

161

2.18

4.48

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

161

1138

1.42

4.44

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

365

1.76

4.43

1.4

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

764

6578

1.18

4.38

2.3

2.4

1.9

1.8

1.48

685

5801

(3022948) Iron [Moles/volume] in Serum or Plasma

1035

9130

1.16

4.36

2.9

2.5

umol/l

12.5

12.8

0.44

960

8433

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.73

4.34

3.2

2.7

mg/l

69.7

19.9

—

(3023520) Reticulocytes [#/volume] in Blood

591

4979

1.20

4.33

2.2

2.5

e9/l

72.4

68.8

1.31

455

3793

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

198

2.03

4.26

1.6

1.8

127.3

155.8

2.31

185

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

125

855

1.47

4.12

1.8

1.9

u/l

6784.4

3085.0

0.72

326

(3003338) MCHC [Mass/volume]

4869

47050

1.11

4.12

25.6

18.8

g/l

331.7

331.9

0.55

4821

46684

(4035726)

449

5413

0.82

4.09

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

104

686

1.52

4.09

1.7

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

330

1.76

4.08

1.0

1.1

mg/l

330.3

294.4

0.22

290

(3034426) Prothrombin time (PT)

156

2.12

3.98

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4094

39241

1.10

3.98

5.1

4.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.43

3.98

1.1

—

(3001604) Monocytes [#/volume] in Blood

2973

28054

1.10

3.97

5.9

5.8

e9/l

0.6

0.42

2614

23990

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2590

24273

1.11

3.97

2.1

2.0

pmol/l

92.4

95.6

3.04

1374

12375

(3019198) Lymphocytes [#/volume] in Blood

3050

28821

1.10

3.96

5.9

5.8

e9/l

1.8

1.9

3.03

2697

25163

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

336

2696

1.26

3.94

1.8

1.6

g/l

1.6

0.19

297

2307

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.72

3.91

1.5

2.1

umol/l

20.7

18.1

0.35

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

764

6641

1.17

3.91

3.5

4.2

u/l

245.5

245.6

0.00

723

6268

(3006315) Basophils [#/volume] in Blood

2987

28210

1.10

3.90

5.9

5.8

e9/l

0.0

0.43

2626

24141

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

448

3714

1.22

3.90

2.3

2.4

au/ml

27.6

23.3

0.25

177

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

139

983

1.42

3.87

1.5

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

894

7877

1.15

3.83

3.1

2.5

22.8

22.3

0.34

745

6660

(3022313) Gas panel - Capillary blood

323

2592

1.26

3.80

4.8

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1350

14854

0.89

3.79

4.2

3.4

—

(40768793) Breast Pathology biopsy report

1401

0.67

3.77

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

111

1602

0.69

3.77

5.6

4.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.73

3.74

1.1

1.2

—

(4010399)

498

4192

1.20

3.71

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

219

1678

1.31

3.71

1.5

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

179

1333

1.35

3.68

2.2

g/l

128.2

127.8

0.06

120

955

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.79

3.68

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

189

1.96

3.66

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

568

6629

0.84

3.66

3.4

4.1

ug/l

19.6

26.8

0.45

484

5377

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

253

1.82

3.65

2.5

2.3

—

(40758558) Short blood count panel - Blood

1579

14471

1.12

3.64

6.2

6.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.43

3.61

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1011

0.62

3.58

1.5

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

407

3381

1.22

3.50

1.2

1.3

au/ml

45.2

49.1

0.16

152

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5172

53083

0.90

3.47

6.0

5.9

mmol/mol

40.0

0.24

4838

48666

(3028707) Methadone [Presence] in Urine by Screen method

464

1.58

3.44

2.0

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

1971

18326

1.10

3.44

3.2

3.1

mmol/l

7.1

7.4

1.26

1708

15248

(40767503) Oxygen content in Capillary blood by calculation

170

1272

1.34

3.42

2.8

2.5

15.9

16.0

0.16

643

(3028271) Lactate [Moles/volume] in Capillary blood

132

949

1.40

3.40

2.0

mmol/l

1.8

1.7

0.51

115

931

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

238

1.81

3.37

1.0

1.1

u/l

1.1

0.17

122

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.83

3.35

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

257

2042

1.27

3.33

3.0

2.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

3.29

1.4

1.2

—

(40761536) Microorganisms panel - Urine sediment

406

4833

0.83

3.29

5.5

4.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

2.11

3.28

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

197

1517

1.31

3.26

1.4

iu/ml

7.8

14.4

—

(3014271) Vancomycin [Susceptibility]

293

1.71

3.25

3.1

2.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

1060

1.37

3.23

6.7

5.8

iu/ml

972.4

1778.2

0.24

161

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.67

3.22

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

116

2.16

3.21

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

133

968

1.38

3.21

2.2

1.8

—

(40768443) Skin Pathology biopsy report

211

2686

0.78

3.20

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1005

9037

1.13

3.18

3.3

2.9

e6/l

2.8

2.6

0.17

556

4899

(3017569) Oxygen content in Arterial blood

280

1.72

3.18

1.7

2.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1950

18185

1.10

3.16

3.4

3.2

u/l

33.7

34.8

0.27

1841

17166

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

299

2436

1.24

3.13

2.3

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1405

12895

1.11

3.12

1.7

pmol/l

23774335.3

28656899.1

0.15

1203

10584

(3014148) Varicella zoster virus Ab [Titer] in Serum

500

1.53

3.12

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

163

1231

1.33

3.11

1.9

1.7

mu/l

301.8

297.8

0.06

149

1125

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.80

3.08

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

476

4067

1.18

3.05

2.4

2.8

g/l

10.5

0.03

421

3711

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

195

1.85

3.05

1.1

miu/ml

1377.6

1561.9

0.46

195

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

392

1.59

3.03

1.6

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

941

8453

1.13

3.03

2.9

2.4

g/l

2.3

0.63

871

7804

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

262

1.72

3.02

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

262

1.72

3.02

1.2

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

293

1.68

2.99

1.4

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

402

1.57

2.97

1.6

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

219

1.79

2.96

2.4

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

112

804

1.40

2.96

2.1

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

287

1.68

2.93

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

287

1.68

2.93

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

128

1721

0.74

2.93

1.4

1.3

—

(44790049)

623

1.45

2.91

1.3

1.5

—

(44790048)

623

1.45

2.91

1.3

1.5

—

(44790047)

623

1.45

2.91

1.3

1.5

—

(44806118)

623

1.45

2.91

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

342

1.61

2.90

1.1

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

626

5498

1.15

2.84

2.1

2.2

g/l

0.2

0.13

581

5113

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

275

2248

1.23

2.83

5.2

3.8

mmol/l

25.0

0.15

254

2053

(3011288) Drugs identified in Urine by Screen method

685

1.42

2.83

2.9

2.5

—

(3012501) Base excess in Blood by calculation

170

1312

1.30

2.82

4.6

4.4

mmol/l

2.8

2.6

0.45

110

906

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4632

44977

1.09

2.82

7.8

7.6

u/l

78.4

79.0

0.34

4398

42206

(3013290) Carbon dioxide [Partial pressure] in Blood

170

1313

1.30

2.81

4.6

4.4

kpa

5.0

0.11

160

1286

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5770

56602

1.11

2.78

19.8

14.5

mg/l

24.6

24.7

0.01

4956

45028

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

346

1.59

2.78

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.27

2.76

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

565

1.46

2.73

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

290

2398

1.22

2.69

1.3

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.75

2.67

3.9

5.7

—

(3012516) Albumin [Mass/volume] in Urine

1887

17692

1.09

2.66

3.3

3.2

mg/l

348.6

374.3

0.10

1249

10955

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

171

1333

1.29

2.65

1.5

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

153

1176

1.31

2.64

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

153

1176

1.31

2.64

1.3

—

(44806071)

2.66

2.62

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

117

867

1.36

2.59

1.4

1.2

u/ml

278.2

282.1

0.05

534

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

149

1.88

2.55

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

169

1324

1.28

2.54

4.6

4.5

kpa

8.5

0.06

159

1296

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

292

1.61

2.52

1.1

—

(3013115) Eosinophils [#/volume] in Blood

3047

29178

1.08

2.52

6.1

6.0

e9/l

0.2

0.07

2714

25363

(3013650) Neutrophils [#/volume] in Blood by Automated count

3407

32765

1.08

2.51

8.5

9.1

e9/l

4.4

4.1

7.08

3042

28476

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

584

5156

1.14

2.49

2.9

ng/l

229.9

204.6

0.70

522

4710

(1617658) Protocol used for examination of sentinel lymph nodes

484

0.56

2.46

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.38

2.46

7.9

13.4

mmol/l

5.4

5.2

0.07

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

1459

1.26

2.40

3.8

2.9

mg/l

1.6

0.32

167

1317

(3011648) Oxygen content in Venous blood

441

1.48

2.39

2.4

2.1

10.5

10.9

0.41

441

(3051611) Lipemic interference index of Serum or Plasma

565

1.42

2.39

2.9

3.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.35

2.38

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

123

936

1.32

2.32

1.4

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1318

0.74

2.32

4.0

3.4

mg/l

34.0

27.1

0.69

841

(40759836) Histone Ab [Presence] in Serum by Immunoblot

387

1.50

2.32

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

387

1.50

2.32

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

268

2237

1.21

2.30

2.2

1.8

—

(3027008) Opiates [Presence] in Urine

137

1060

1.30

2.30

2.2

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

388

1.50

2.29

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

300

1.57

2.29

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

136

1052

1.30

2.29

2.2

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

246

1.63

2.27

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

295

2494

1.19

2.22

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1.49

2.22

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1.49

2.22

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1.49

2.22

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

628

0.63

2.20

3.1

3.2

13.1

13.3

0.50

621

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

205

1678

1.23

2.16

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

234

1.63

2.16

2.0

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

234

1.63

2.16

2.0

2.3

—

(3028300) Cannabinoids [Presence] in Urine

136

1062

1.29

2.15

2.2

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.16

2.14

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

578

1.39

2.13

2.4

1.4

iu/ml

53.1

21.3

1.11

(3003694) ABO and Rh group [Type] in Blood

1549

14529

1.08

2.13

1.3

—

(4281824)

682

0.66

2.12

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

197

1.68

2.11

2.6

1.9

u/ml

1069.2

73007.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

404

1.46

2.11

1.2

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

167

1.74

2.10

1.4

1.3

g/l

0.3

0.23

129

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

332

0.51

2.10

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

236

1.61

2.09

2.1

2.3

—

(40768795) Lymph node Pathology biopsy report

619

0.64

2.08

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1964

18622

1.08

2.04

3.9

mg/mmol

12.7

8.3

2.49

1269

11566

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

155

1240

1.26

2.03

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

1384

1.24

2.03

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

127

993

1.28

2.01

1.6

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1405

14982

0.92

2.00

4.2

4.3

22.1

21.9

0.20

702

7506

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

148

1.76

1.98

1.1

—

(3027944) Amphetamines [Presence] in Urine

132

1040

1.27

1.97

2.2

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1306

12203

1.09

1.97

4.3

4.5

—

(3037522) Nuclear Ab [Titer] in Serum

813

7440

1.10

1.93

1.3

titre

486.9

522.7

0.22

181

1597

(3014051) Protein [Presence] in Urine by Test strip

105

1353

0.77

1.89

2.3

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

185

2236

0.82

1.89

3.0

3.5

u/ml

806.1

1943.0

0.80

162

1909

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

1022

1.27

1.86

1.3

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.86

1.86

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

190

1573

1.21

1.84

2.0

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

221

1.59

1.84

2.0

1.9

ug/l

53.0

51.7

0.03

213

(3028433) Virus identified in Specimen by Culture

190

1.63

1.83

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

682

0.69

1.82

1.1

u/ml

1.8

3.2

0.90

284

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.17

1.82

2.0

1.2

mu/l

2.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

276

2370

1.17

1.79

1.7

1.9

u/l

37.4

39.5

0.88

234

2083

(1616796) Gas panel - Central venous blood

158

1290

1.23

1.77

4.9

3.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

214

1801

1.19

1.76

1.9

2.1

g/l

37.5

37.7

0.21

181

1541

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

264

3070

0.85

1.76

3.0

3.8

u/ml

31.8

66.1

4.83

257

2955

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.98

1.74

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

389

1.42

1.72

1.0

ng/l

602.0

721.7

0.97

256

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.85

1.71

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

361

3178

1.14

1.69

1.8

—

(37021550) Renin [Units/volume] in Plasma --upright

133

1.73

1.69

1.4

1.3

mu/l

81.4

75.2

0.05

101

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

1.69

2.1

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5113

52025

0.94

1.68

5.1

4.8

mu/l

1.9

2.2

2.02

4751

47135

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

392

1.41

1.65

1.0

ng/l

46.5

45.6

0.04

260

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

196

1.58

1.65

1.1

u/ml

1.2

31.5

—

(3022145) Colonoscopy Study observation

596

6545

0.90

1.64

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

195

1640

1.19

1.64

1.6

1.7

—

(3037121) Protein [Mass/volume] in Urine

232

1982

1.18

1.63

3.2

3.1

g/l

0.3

0.47

101

792

(3002030) Lymphocytes/100 leukocytes in Blood

2618

27149

0.94

1.62

6.4

6.1

26.4

27.5

6.20

2447

25072

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

1.65

1.61

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

454

1.37

1.60

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2411

23180

1.06

1.59

3.1

2.8

ug/l

138.4

140.5

0.14

2235

21247

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.50

1.59

1.5

1.6

umol/24h

284.4

348.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

214

1.54

1.59

1.3

3.8

mg/l

78.8

63.4

0.27

144

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

323

2838

1.14

1.58

1.8

1.7

—

(3042517) Benzodiazepines panel - Urine

2.69

1.58

2.0

1.3

—

(3022621) pH of Urine by Test strip

346

3909

0.88

1.57

3.0

3.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.82

1.57

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

405

1.39

1.57

1.3

1.2

titre

120.7

152.5

0.39

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

405

1.39

1.57

1.3

1.2

—

110.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

390

1.39

1.53

1.0

ng/l

353.7

338.8

0.11

264

(3022096) Basophils/100 leukocytes in Blood

2468

25595

0.94

1.50

6.4

6.0

0.7

1.28

2317

23689

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

1628

1.18

1.50

1.6

iu/ml

0.1

7.5

0.97

354

(3026692) Albumin [Mass/volume] in Peritoneal fluid

146

1.65

1.50

1.5

1.4

g/l

13.1

13.2

0.02

116

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

768

0.74

1.48

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

189

1603

1.18

1.48

1.9

2.2

g/l

0.0

0.18

166

1459

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

139

1.66

1.48

1.2

pmol/l

354.6

313.6

0.27

(3027456) Digoxin [Moles/volume] in Serum or Plasma

147

1220

1.21

1.46

3.6

3.0

nmol/l

0.8

0.00

120

914

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.37

1.45

1.0

1.2

u/l

7.1

18.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

274

2397

1.15

1.45

1.1

titre

68.0

203.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

140

1.64

1.44

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

710

6557

1.09

1.44

3.0

2.7

umol/l

7.8

8.7

0.54

599

5713

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

851

1.25

1.44

1.9

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.12

1.44

2.3

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

472

1.34

1.44

2.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.13

1.44

1.4

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

148

1.62

1.43

5.1

7.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

252

2194

1.15

1.43

2.0

2.3

g/l

3.1

0.18

195

1702

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

303

1.42

2.0

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

303

1.42

2.0

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

303

1.42

2.0

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

303

1.42

2.0

2.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

1.47

1.41

1.8

1.7

nmol/l

11.0

6.3

0.27

200

(3045788) Cell count panel - Pleural fluid

552

1.31

1.41

1.5

—

(3045424) Erythrocytes [Presence] in Urine

1009

0.78

1.41

1.4

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

565

0.71

1.40

1.3

1.4

nmol/l

0.6

0.3

0.74

409

(4146454)

657

0.73

1.40

2.8

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

1318

1.20

1.39

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1577

1.18

1.38

1.9

2.2

g/l

0.0

0.00

166

1454

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.08

1.38

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

812

1.25

1.37

1.3

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

120

0.42

1.37

3.6

3.0

u/l

112.4

2314.9

—

112

(3000093) Morphology [Interpretation] in Blood Narrative

520

1.31

1.37

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

617

1.28

1.36

1.7

2.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

281

1.43

1.35

1.5

1.4

nmol/l

1.0

1.2

0.59

218

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

110

895

1.23

1.35

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

315

1.40

1.34

2.0

1.8

u/field

2.8

2.5

0.08

223

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

2188

1.15

1.34

1.8

2.2

g/l

9.7

10.1

0.82

201

1837

(3028026) IgM [Mass/volume] in Serum or Plasma

356

3188

1.12

1.33

1.7

1.9

g/l

1.2

1.4

1.03

315

2889

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.04

1.32

2.3

2.0

—

(3000494) Fungus identified in Specimen by Culture

728

6763

1.09

1.31

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

899

1.23

1.30

1.3

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

582

5356

1.09

1.30

2.9

2.4

u/l

41.2

46.2

0.18

512

4553

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.09

1.30

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

161

1366

1.18

1.29

1.5

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.35

1.29

1.4

1.7

pmol/l

17.3

22.1

—

(3045414) Leukocytes [Presence] in Urine

233

2659

0.87

1.28

1.9

—

(3006504) Eosinophils/100 leukocytes in Blood

2554

26367

0.95

1.27

6.3

6.0

2.9

0.03

2398

24395

(3013727) Leukocytes other/100 leukocytes in Blood

192

0.52

1.27

1.4

3.5

64.2

54.2

—

184

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

227

1983

1.15

1.26

2.1

2.3

g/l

0.5

0.9

1.54

188

1689

(44816559) Phosphatidylethanol [Mass/volume] in Blood

106

867

1.23

1.25

1.5

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1014

0.80

1.25

2.5

3.7

1.7

1.6

0.17

766

(3049717) Cytology report of Urine Cyto stain

259

2288

1.14

1.23

2.5

2.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.23

1.3

2.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

131

1.60

1.23

5.5

7.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

444

0.70

1.21

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

2594

26743

0.95

1.21

6.2

5.9

58.4

57.5

3.60

2438

24809

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

431

0.69

1.20

1.3

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

315

1.37

1.18

1.6

1.5

u/l

5.8

6.6

0.29

264

(3025159) Blasts/100 leukocytes in Blood

405

4446

0.91

1.17

3.9

4.1

0.1

0.3

0.75

1120

(3019069) Monocytes/100 leukocytes in Blood

2574

26525

0.95

1.17

6.6

6.3

8.7

0.08

2428

24650

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1.43

1.17

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

186

0.54

1.16

1.2

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1727

1.15

1.9

2.1

g/l

0.0

1.51

175

1576

(3022806) Fractional oxyhemoglobin in Capillary blood

777

1.23

1.15

2.1

1.9

89.0

89.4

0.33

770

(3032057) Clostridioides difficile [Presence] in Stool

134

1.57

1.14

2.2

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

129

1089

1.19

1.13

1.5

1.3

u/l

11.2

11.9

0.17

106

886

(3021879) Hepatitis B virus core Ab [Presence] in Serum

375

3407

1.11

1.12

1.5

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.75

1.12

1.1

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.33

1.12

1.3

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.12

2.0

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

405

1.31

1.12

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

735

1.23

1.11

1.7

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

119

1.60

1.11

1.3

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1172

0.83

1.10

3.6

3.7

58.0

0.00

1172

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

209

1.44

1.10

3.2

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4321

42460

1.05

1.08

4.3

4.1

mm/h

14.1

12.9

4.77

4048

38957

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

786

1.21

1.05

1.4

1.6

—

(3019225) pH of Specimen

569

6115

0.92

1.05

5.8

4.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3123

31978

0.96

1.05

2.8

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

212

1.42

1.03

1.4

—

(3021589) Normoblasts [#/volume] in Blood

2427

24978

0.96

1.02

10.3

9.7

e9/l

0.0

0.50

2027

20384

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

106

1.61

1.02

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

653

6110

1.08

1.02

4.0

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1615

15536

1.05

1.02

2.9

2.6

umol/l

2950.8

4965.9

1.57

1416

13327

(42870588) Differential panel, method unspecified - Blood

1870

19357

0.95

1.01

5.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

754

1.21

1.00

1.7

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

262

2353

1.12

1.00

1.9

2.2

g/l

7.4

7.5

0.07

196

1736

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

180

1.45

1.00

1.9

1.7

e6/l

1309.5

19258.0

1.06

102

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.00

1.00

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

390

0.72

0.98

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2349

1.12

0.97

1.9

2.2

g/l

3.8

0.13

193

1659

(3025315) Body weight

1.95

0.97

4.9

4.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5976

59241

1.06

0.97

23.9

16.7

mmol/l

139.4

139.7

10.06

5880

57721

(3043238) Trisomy 21 risk [Likelihood] in Fetus

342

0.70

0.96

1.3

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2351

1.11

0.96

1.9

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

149

1295

1.15

0.95

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

797

1.19

0.93

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

118

0.51

0.93

2.7

7.3

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.22

0.93

1.0

1.3

—

1.2

—

(3020650) Glucose [Presence] in Urine

144

0.56

0.93

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

0.55

0.92

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

725

1.20

0.92

1.5

e6/l

7045.5

2153.0

0.53

535

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

374

1.29

0.92

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.82

0.92

1.2

1.3

umol/24h

2.2

1.6

—

(40765096) Chromosome analysis panel by Banding

171

0.58

0.91

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

439

4734

0.92

0.91

3.9

4.1

0.2

0.19

122

1342

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

800

1.19

0.90

1.3

1.4

—

(3019977) pH of Arterial blood

331

1.30

0.90

2.8

7.4

0.34

117

(4024509)

609

0.79

0.90

1.6

—

(4094501)

141

1615

0.87

0.89

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

262

1.34

0.89

1.2

1.1

—

3.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.69

0.88

1.7

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

151

1323

1.14

0.88

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

574

1.22

0.88

1.3

e6/l

43380.6

107201.1

1.32

393

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

381

0.73

0.87

1.7

2.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.86

0.87

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

288

0.69

0.87

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

766

8081

0.94

0.86

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

334

0.72

0.86

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

208

1864

1.12

0.86

1.4

1.3

iu/l

32.0

34.5

0.47

175

1611

(3033923) Metanephrine [Moles/time] in 24 hour Urine

120

1.50

0.85

1.2

umol/24h

1.6

0.7

—

(3005033) Fetal Nuchal fold Thickness US

331

0.72

0.82

1.2

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

365

0.74

0.82

5.6

6.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

399

0.75

0.82

1.7

2.0

13.2

15.5

0.41

159

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.88

0.81

2.5

2.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

249

0.68

0.81

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

206

1.36

0.81

2.1

2.0

e6/l

1993.6

4329.4

0.26

150

(3041806) Other cells [#/volume] in Blood by Manual count

1.70

0.80

1.4

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

164

0.61

0.80

1.9

2.3

nmol/l

154.5

143.9

—

142

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

555

1.21

0.79

3.8

3.7

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.78

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

190

1.37

0.78

1.3

64.7

54.2

0.80

164

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

429

1.24

0.78

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

148

1.42

0.77

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

648

1.19

0.77

1.4

e6/l

83286.5

66329.6

0.19

381

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

0.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

100

861

1.16

0.77

1.6

1.5

g/l

0.7

0.32

641

(3024522) Salmonella sp identified in Specimen by Organism specific culture

742

1.17

0.75

1.7

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

163

1822

0.89

0.75

1.7

mg/l

3.8

0.01

117

1309

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

381

0.76

0.74

1.5

1.3

—

67.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.08

0.74

13.0

9.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.67

0.74

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

403

0.77

0.74

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

402

0.77

0.73

1.2

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5982

59396

1.05

0.73

23.5

16.8

mmol/l

4.0

1.81

5876

57775

(3030313) Adrenal Ab [Titer] in Serum

2.00

0.72

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1087

0.86

0.72

2.1

1.7

nmol/l

0.9

0.8

0.46

907

(3043410) Blood group antigens tested for on Red Blood Cells

142

1.41

0.72

1.3

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

1318

1.13

0.72

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

737

1.17

0.71

1.7

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

400

0.77

0.71

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

400

0.77

0.71

1.2

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

535

1.20

0.71

1.6

1.8

—

1184.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

738

1.17

0.71

1.7

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

229

0.70

1.9

2.0

—

(3008898) HLA-B27 [Presence]

146

1633

0.89

0.69

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

741

1.16

0.68

1.7

1.5

—

(4062490)

556

1.19

0.68

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

356

3812

0.93

0.67

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

180

1985

0.90

0.67

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

892

9293

0.95

0.66

1.3

u/ml

14.6

12.8

0.17

372

3533

(3050794) Legionella sp Ab [Presence] in Serum

1.63

0.66

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

789

0.85

0.66

1.1

iu/ml

76.1

13647.7

0.54

174

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

350

0.77

0.65

1.3

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.59

0.65

2.0

1.8

umol/l

64.0

44.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

190

0.68

0.65

1.0

1.2

g/l

44.4

39.2

—

102

(3002179) Metamyelocytes/100 leukocytes in Blood

427

4535

0.94

0.64

3.9

4.0

0.8

0.6

0.46

1040

(3017181) Myelocytes/100 leukocytes in Blood

470

4974

0.94

0.63

3.9

4.1

1.2

1.0

0.52

137

1438

(3002523) Influenza virus A Ag [Presence] in Specimen

676

0.84

0.62

1.1

—

(3014891) Appearance of Pleural fluid

1.52

0.62

2.3

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

436

0.80

0.62

2.3

32.0

38.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

675

0.84

0.62

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

553

1.18

0.62

1.4

g/l

0.5

0.4

0.45

380

(3028192) IgG subclass 2 [Mass/volume] in Serum

553

1.18

0.62

1.4

g/l

2.9

0.06

381

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

369

0.79

0.61

1.2

1.4

pmol/l

59.6

141.2

—

115

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

176

0.68

0.61

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

693

1.16

0.61

1.3

u/ml

27.5

46.4

0.66

(3027135) IgG subclass 1 [Mass/volume] in Serum

554

1.17

0.61

1.4

g/l

6.5

6.8

0.21

381

(3000285) Sodium [Moles/volume] in Blood

1.48

0.60

1.3

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

363

3407

1.07

0.60

3.1

3.2

pmol/l

4.5

4.4

0.25

322

3015

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

345

0.78

0.60

1.5

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

105

1.43

0.60

3.7

7.5

—

(3012441) Differential panel - Pleural fluid

620

1.16

0.60

1.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

122

1.39

0.60

1.4

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.54

0.59

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

1.54

0.59

5.1

2.4

umol/l

276.0

548.9

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

140

1262

1.11

0.59

1.3

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

291

3119

0.93

0.59

3.2

2.7

e6/l

0.5

0.3

0.56

282

3049

(4212803)

1.56

0.58

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

306

3271

0.93

0.58

2.3

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

343

0.79

0.58

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

309

0.78

0.57

2.0

2.8

36.9

38.1

—

113

(3038177) Helicobacter pylori Ab [Presence] in Serum

840

0.87

0.57

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

132

1.36

0.57

1.4

1.2

umol/l

17.0

16.6

0.16

117

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.62

0.55

4.0

3.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.62

0.55

1.0

—

(3000492) Spirometry study

493

5182

0.95

0.55

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

536

0.84

0.54

1.1

u/ml

6.9

2.4

0.74

202

(36660697) Celiac disease serology panel - Serum

389

4112

0.94

0.53

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

192

1771

1.09

0.52

1.5

1.4

ug/g

300.5

272.6

1.05

114

1058

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

295

1.22

0.52

1.3

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

268

1.23

0.52

1.8

1.6

ug/l

20.7

8.3

0.59

233

(3048689) Calprotectin [Mass/mass] in Stool

658

6315

1.05

0.52

2.1

2.2

ug/g

157.0

140.8

0.48

529

4934

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

1.37

0.52

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

0.62

0.52

1.5

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

126

1389

0.91

0.51

1.0

1.1

u/ml

4.6

8.9

—

139

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

649

0.86

0.50

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

412

0.82

0.50

1.8

2.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

1.36

0.50

1.6

ng/l

84.6

140.6

2.15

118

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

768

7956

0.96

0.48

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.52

0.48

1.0

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

463

0.84

0.47

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

473

0.84

0.46

1.4

1.6

—

(44806420)

176

0.74

0.45

2.3

2.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.62

0.45

1.0

ug/l

75.8

75.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.59

0.45

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.59

0.45

1.2

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.43

0.45

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

228

1.23

0.45

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

292

1.20

0.45

1.7

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

164

0.73

0.45

1.8

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.40

0.44

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.45

0.44

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.45

0.44

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.45

0.44

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

491

0.85

0.43

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

140

1520

0.92

0.43

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1179

11493

1.03

0.43

1.2

u/ml

1.1

1.8

3.58

356

3009

(3035933) Granulocytes/100 leukocytes in Blood

128

0.70

0.43

2.0

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.26

0.43

3.5

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.26

0.43

3.5

2.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

130

0.69

0.43

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

123

1126

1.09

0.43

1.3

1.2

u/ml

63.3

44.4

0.49

120

(3017509) Phencyclidine [Presence] in Urine

1.61

0.43

1.0

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.43

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

240

0.79

0.42

1.3

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.56

0.42

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

327

0.83

0.41

2.4

1.8

umol/l

7.2

9.3

0.29

223

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.36

0.41

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

128

1178

1.09

0.40

1.4

1.3

miu/ml

181.0

212.6

0.52

520

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.47

0.40

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

508

0.87

0.40

3.9

5.2

u/ml

471.0

76.4

—

147

(3004775) Volume in Urine collected for unspecified duration

476

0.86

0.40

2.7

2.2

674.6

633.3

0.32

305

(3020491) Glucose [Moles/volume] in Blood

401

0.85

0.40

1.7

2.1

mmol/l

6.8

0.01

265

(3033799) Differential panel - Peritoneal fluid

186

1.24

0.40

1.6

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

177

1.24

0.40

1.8

1.6

ug/l

10.8

8.9

0.73

177

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

12.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

259

0.81

0.39

11.0

11.8

nmol/l

837.6

826.2

0.03

242

(3034860) Kappa light chains.free [Mass/volume] in Serum

209

1965

1.07

0.39

2.8

3.4

mg/l

76.6

86.7

0.10

176

1579

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

169

1.24

0.38

1.9

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

601

0.88

0.38

1.1

u/ml

1.8

2.2

—

146

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

674

0.89

0.37

1.3

1.2

mmol/l

7.4

7.5

0.05

496

(3042111) Morphology [Interpretation] in Bone marrow Narrative

109

1001

1.09

0.37

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

781

1.10

0.37

1.1

—

(3011412) CD3 cells [#/volume] in Blood

504

0.87

0.37

2.4

e9/l

1.1

0.18

314

(3001686) Cold agglutinin [Titer] in Serum or Plasma

112

0.71

0.37

1.1

1.2

—

103.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.35

0.37

1.2

—

(3021788) Differential panel - Synovial fluid

100

1091

0.92

0.37

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

158

1475

1.07

0.37

1.2

titre

86.9

160.5

0.82

123

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

267

0.82

0.36

16.6

16.0

nmol/l

1458.9

1435.7

0.04

257

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

167

1564

1.07

0.36

1.3

u/ml

47.2

39.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

153

1.24

0.35

1.5

ug/l

0.4

0.19

(44813793)

357

1.15

0.35

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

270

2570

1.05

0.35

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

956

9794

0.97

0.34

1.3

iu/ml

45.0

34.2

1.00

295

3080

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

732

0.90

0.34

1.1

g/l

1.5

0.47

657

(3032868) Hemoglobin electrophoresis panel in Blood

1.36

0.34

1.8

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

514

4968

1.04

0.34

4.6

3.9

mmol/l

1.2

2.44

452

4310

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.32

0.33

2.5

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

109

1.28

0.33

1.1

1.3

—

(3047189) Immunofixation for 24 hour Urine

293

1.16

0.33

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

539

1.11

0.33

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

164

1.22

0.32

1.2

1.3

ug/l

39.3

489.1

1.36

(3044941) Cell count panel - Synovial fluid

103

952

1.08

0.32

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

266

1.17

0.32

1.3

1.4

umol/l

22.7

24.1

0.10

251

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

124

1328

0.93

0.31

2.7

3.4

u/ml

1112.6

694.9

0.21

118

1203

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

207

1965

1.06

0.31

2.8

3.4

mg/l

38.2

49.9

0.78

177

1582

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.32

0.30

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

357

0.87

0.30

1.2

u/l

15.7

20.8

0.90

300

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

543

1.11

0.30

1.3

1.5

24.5

30.0

0.66

330

(3000919) Neutrophils/100 leukocytes in Pleural fluid

174

0.80

0.29

1.5

1.4

34.2

18.9

1.11

158

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

194

1.19

0.29

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

493

0.89

0.29

1.1

u/ml

8.5

3.4

—

184

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

241

1.16

0.29

1.3

1.5

ug/l

2.2

4.3

0.96

177

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

1435

1.06

0.28

2.5

2.3

ug/min

104.2

106.5

0.02

848

(3000475) Leukocytes [#/volume] in Synovial fluid

157

1484

1.06

0.28

1.6

e6/l

22902.4

13057.4

1.07

128

1074

(40757373) Influenza virus identified in Isolate

112

1.25

0.28

1.4

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

659

0.91

0.28

3.5

3.6

u/ml

49.2

41.8

0.18

651

(3027035) Albumin [Mass/time] in 24 hour Urine

1.29

0.28

1.5

1.2

—

612.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

312

0.86

0.28

1.4

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

333

0.87

0.27

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.25

0.27

4.5

2.5

u/field

0.4

0.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

461

1.11

0.27

1.4

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

914

1.07

0.26

1.4

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

159

1.20

0.26

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.26

0.26

1.8

1.3

mmol/l

1.1

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.22

0.25

1.7

1.4

72.9

74.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

151

1.19

0.25

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

170

0.82

0.25

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

148

0.81

0.24

1.2

2.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

137

0.80

0.24

1.1

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

832

1.07

0.23

1.6

1.5

g/l

31.7

32.8

0.33

749

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

307

0.88

0.23

2.9

4.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

369

0.89

0.22

1.2

u/l

86.5

82.8

0.17

319

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

159

1517

1.05

0.22

1.8

1.9

mg/l

10.8

11.7

0.72

146

1401

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.25

0.22

1.8

umol/l

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.27

0.22

2.2

2.1

pmol/l

68.0

72.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

189

0.85

0.22

1.8

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

145

1381

1.05

0.22

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

632

1.08

0.21

1.1

—

(3006270) Folate [Moles/volume] in Blood

534

0.92

0.21

1.3

1.2

nmol/l

364.7

348.5

0.21

440

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.19

0.21

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

2.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

199

1913

1.04

0.21

2.8

3.3

ratio

4.5

2.7

0.31

149

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

575

1.08

0.21

1.1

—

2.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

647

0.93

0.21

1.2

u/l

41.8

60.0

5.09

425

(3019174) dRVVT (LA screen)

1.16

0.21

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.16

0.21

1.6

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

105

0.76

0.21

2.3

2.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

145

0.83

0.21

1.1

—

(3002619) Bacteria identified in Specimen by Culture

117

1.20

0.20

1.0

1.2

—

(21494434) Karyotype in Bone marrow

509

1.08

0.20

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.22

0.20

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.22

0.20

2.5

1.7

—

(3012898) Urea [Moles/volume] in Urine

1.22

0.20

1.3

1.2

mmol/l

129.3

169.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

717

0.93

0.20

1.3

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

624

0.93

0.19

3.0

3.8

63.4

57.9

1.15

390

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

1662

1.04

0.19

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

133

0.83

0.19

3.5

2.2

mmol/l

5.9

7.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.15

0.19

2.3

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.15

0.19

1.2

3.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

724

1.06

0.19

1.3

1.6

63.4

58.5

0.58

452

(3041918) Cholesterol [Moles/volume] in Pleural fluid

118

1.19

0.19

1.6

1.2

mmol/l

2.2

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

559

1.07

0.19

1.7

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1012

9976

1.02

0.19

1.4

1.5

g/l

2.5

0.24

626

5890

(40768441) Liver Pathology biopsy report

424

1.09

0.18

1.3

—

(3044927) Protein electrophoresis panel - Urine

618

1.07

0.18

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

776

0.94

0.18

1.1

u/ml

2.5

1.5

0.17

304

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

328

1.10

0.18

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

599

1.07

0.18

1.7

—

(3044007) Cell count panel - Peritoneal fluid

166

1.14

0.18

1.9

2.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

166

1.14

0.18

1.1

1.3

29.8

33.8

0.17

110

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

152

1461

1.04

0.17

1.3

u/ml

4.5

7.5

0.94

220

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

329

1.09

0.17

1.1

1.0

—

(3036603) Volume of Urine

372

0.91

0.17

1.5

1.7

1750.0

1854.5

—

(40768797) Stomach Pathology biopsy report

823

8108

1.02

0.17

1.3

1.2

—

(3024263) Appearance of Synovial fluid

330

0.91

0.17

1.2

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

454

0.92

0.16

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.18

0.16

1.5

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

374

3824

0.98

0.16

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

273

1.10

0.16

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

116

1112

1.04

0.16

4.8

3.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

151

0.86

0.15

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

623

1.06

0.15

3.7

4.5

—

(40761511) CBC panel - Blood by Automated count

5849

58619

0.99

0.15

18.6

13.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

368

3760

0.98

0.15

2.2

nmol/l

12.2

12.7

0.42

316

3297

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

121

1.16

0.15

3.6

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

728

0.95

0.15

1.1

—

(3015183) Erythrocyte sedimentation rate

223

0.90

0.14

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

139

1342

1.04

0.14

1.9

1.8

iu/l

3.3

4.7

1.73

475

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

626

1.05

0.14

1.3

u/l

34.8

33.3

0.13

501

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

345

3380

1.02

0.14

1.2

iu/ml

95.3

143.6

2.02

125

1257

(3020874) Milk IgE Ab [Units/volume] in Serum

243

0.91

0.13

1.0

u/ml

0.5

0.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

103

1.17

0.13

2.1

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

149

1443

1.03

0.13

1.3

u/ml

3.0

4.7

0.30

139

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

124

1197

1.04

0.13

1.3

1.2

u/ml

1.5

5.1

1.12

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3603

35887

1.01

0.12

3.6

3.1

u/l

56.6

50.7

2.75

3362

32963

(3004451) EKG impression Narrative

297

1.08

0.12

1.4

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

375

1.07

0.12

1.6

1.4

u/ml

1.7

1.2

0.12

187

(3001964) Herpes simplex virus Ag [Presence] in Specimen

158

0.89

0.12

1.4

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

218

2129

1.02

0.12

1.1

u/ml

1.0

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

446

0.94

0.11

1.4

1.5

u/ml

24.8

21.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

752

0.96

0.11

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

333

0.93

0.11

2.5

e6/l

448.2

504.8

0.39

281

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

863

0.96

0.11

1.1

—

(4133840)

136

0.88

0.11

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2404

23921

1.01

0.10

2.3

2.2

nmol/l

77.7

79.0

1.39

2160

21340

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

130

1338

0.97

0.10

1.9

1.8

nmol/l

43.3

42.4

0.13

125

1287

(3017704) Immunofixation for Urine

342

0.94

0.10

1.2

1.6

—

(40768806) Pleura Pathology biopsy report

632

1.04

0.10

1.5

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

760

0.96

0.10

2.6

2.2

mg/l

17.3

25.2

0.85

201

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

393

0.94

0.10

1.4

1.6

u/l

5.5

5.8

0.05

187

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

161

1572

1.02

0.10

1.7

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

1.10

0.09

1.5

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.11

0.09

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4351

43408

1.01

0.08

4.2

4.0

pmol/l

15.0

14.9

2.24

4017

39173

(40760888) Immunoglobulin light chains.free panel - Serum

147

1502

0.98

0.08

2.8

3.5

—

(3037756) Immunofixation for Serum or Plasma

132

1290

1.02

0.08

1.5

1.7

—

(3016750) Collection duration of Urine

338

0.95

0.08

2.7

2.1

min

510.7

494.1

0.63

247

(3025018) Bordetella pertussis Ab [Titer] in Serum

287

0.94

0.08

1.5

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

0.89

0.08

1.1

u/ml

0.3

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.04

0.08

1.1

—

(4015189)

166

1.08

0.07

3.2

2.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

313

1.05

0.07

1.2

1.1

u/l

28.2

24.6

0.17

240

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.81

0.07

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.07

0.07

1.5

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

511

1.04

0.07

2.1

u/field

2.6

1.8

0.38

199

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

314

1.05

0.07

1.2

1.1

u/l

84.7

87.3

0.09

245

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

561

1.03

0.06

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

121

0.91

0.06

3.4

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

168

1.07

0.06

1.1

—

(3045142) Bone marrow Pathology biopsy report

662

1.03

0.05

1.2

1.4

—

(3035880) pH of Pleural fluid

336

1.04

0.05

1.6

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

768

0.98

0.05

2.3

mmol/l

4.0

4.1

0.97

758

(3035285) Chloride [Moles/volume] in Venous blood

768

0.98

0.05

2.3

mmol/l

106.1

105.6

0.68

758

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

252

0.95

0.05

1.1

1.2

—

(3048879) Bone marrow aspiration report

181

0.94

0.05

1.6

1.9

—

(3000012) Reticulocyte production index

343

0.96

0.04

1.2

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

130

1.08

0.04

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

140

1.07

0.04

1.1

1.5

mmol/l

8.1

8.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

322

0.96

0.04

1.2

1.1

iu/ml

4.2

10.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

352

0.97

0.04

2.7

2.6

e6/l

718.3

640.8

0.16

146

(3006922) Hepatitis E virus Ab [Presence] in Serum

358

1.03

0.04

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

388

1.03

0.04

1.2

1.3

mmol/l

7.8

12.1

—

117

(3042631) Mycobacterium sp identified in Specimen

855

1.02

0.04

2.2

2.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

280

1.04

0.03

2.7

3.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

1.08

0.03

1.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

398

4000

0.99

0.03

3.1

e9/l

4.1

0.03

295

3054

(1002224) Polysomnography panel

205

2066

0.99

0.03

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

560

0.98

0.02

2.9

3.1

mg/l

19.0

31.3

1.05

409

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

959

1.01

0.02

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

579

5806

1.00

0.02

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

317

0.98

0.01

1.2

1.3

—

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

326

3269

1.00

0.01

1.3

u/ml

348.6

215.1

0.65

300

3007

(3003888) Timothy IgE Ab [Units/volume] in Serum

683

1.01

0.01

1.1

u/ml

2.7

3.2

0.19

313

(3004616) Nuclear Ab [Presence] in Serum

717

0.99

0.01

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

126

0.95

0.00

3.5

1.9

ug/l

1.3

2.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

154

1.04

0.00

3.6

3.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

236

0.97

0.00

1.2

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

113

0.97

0.00

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

143

0.98

0.00

1.7

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

143

0.98

0.00

1.7

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

143

0.98

0.00

1.7

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

143

0.98

0.00

1.7

1.1

—

(4211845)

302

0.99

0.00

3.3

3.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

121

0.99

0.00

1.1

—

(3006462) Nitrate [Presence] in Urine

279

1.00

0.00

3.5

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

662

1.00

0.00

1.1

u/ml

0.5

1.0

0.79

266

(3037556) Urate [Mass/volume] in Serum or Plasma

171

0.99

0.00

1.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

138

1.01

0.00

1.4

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

150

1.00

0.00

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

838

1.00

0.00

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.00

0.00

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

273

0.99

0.00

1.3

1.5

4.1

3.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.1

—

0.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

131.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.88

0.00

1.0

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.86

0.00

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

6.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.00

0.00

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.93

0.00

4.0

5.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.93

0.00

1.9

1.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018133) Calcium [Moles/volume] in Urine

0.93

0.00

1.4

1.7

mmol/l

2.4

2.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.87

0.00

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.93

0.00

1.3

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

38.5

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_SAHANEUR and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_SAHANEUR	2.173 [1.97, 2.4]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.15

During the follow-up period (1.1.1998 — 31.12.2019), 3919 out of 15897 females with I9_SAHANEUR died.

Males

Parameter	HR [95% CI]	p-value
I9_SAHANEUR	2.285 [2.06, 2.53]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3963 out of 13030 males with I9_SAHANEUR died.

Mortality risk

Mortality risk for people of age

years, who have I9_SAHANEUR.

N-year risk	Females	Males
1	0.19%	0.36%
5	1.138%	2.232%
10	2.866%	5.538%
15	5.712%	10.532%
20	9.658%	17.186%

Relationships between endpoints

↥

Index endpoint: I9_SAHANEUR – Aneurysms, operations, SAH

GWS hits: 13

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Aneurysms, operations, SAH

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints